THE METABOLISM AND TOXICITY OF PHENOTHIAZINE by Mitchell, Stephen Charles
Open Research Online
The Open University’s repository of research publications
and other research outputs




Mitchell, Stephen Charles (1986). THE METABOLISM AND TOXICITY OF PHENOTHIAZINE. The Open
University.
For guidance on citations see FAQs.
c© 1985 The Author
Version: Version of Record
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright




THE METABOLISM AND TOXICITY OF PHENOTHIAZINE
by Stephen Charles M itchell B .S c., Ph.D.
A th e s is  subm itted to  th e  F acu lty  o f  Science o f th e  
Open U n iv ersity  fo r  the  degree o f B atche lo r o f Philosophy
Department o f Chemistry November I 985
ZDaCe. o f  Z4-
ProQ uest Number: 27919410
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent on the quality of the copy submitted.
in the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 27919410
Published by ProQuest LLC (2020). Copyright of the Dissertation is held by the Author.
Ail Rights Reserved.
This work is protected against unauthorized copying under Title 17, United States Code
Microform Edition © ProQuest LLC.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106 - 1346
ABSTRAGT
Phenothiazine, f i r s t  prepared in  1883 during research  in to  a n il in e  
dyes tu f f s ,  i s  the  paren t molecule o f  a  m ultitude o f  drugs which have found 
v a ried  and ex tensive use in  c l in ic a l  p ra c t ic e .  The compound i t s e l f  possesses 
in s e c t ic id a l ,  a n t ib a c te r ia l ,  an tifu n g a l and an th e lm in tic  p ro p e r tie s .  I t s  
major use has been as  a  vermifuge which enabled th e  p ro v is io n  o f  many tons 
o f  in fe c tio n -f re e  food and sheep in te s t in e  (c a tg u t)  which were d esp era te ly  
req u ired  during  World War I I .  For t h i s  reason alone phenoth iazine deserves 
reco g n itio n  a longside p e n ic i l l in  and DDT fo r  i t s  remarkable e f fe c t  on 
mankind.
To be e f fe c tiv e  as  an an th e lm in tic  th e  compound has to  be given in  
la rg e  doses and because o f  i t s  high l i p i d  s o lu b i l i ty  becomes w idely 
d is tr ib u te d  around th e  body. Here i t  undergoes enzym atically  ca ta ly sed  
chemical a l te r a t io n s ,  mainly ox idations o f the  carbon and su lp h u r atoms 
and conjugation re ac tio n s  w ith  g lucuronic and su lp h u ric  a c id s .
The th e rap eu tic  a c tio n s  o f phenothiazine and th e  p roduction  o f i t s  
unwanted to x ic  e f fe c ts  (haem olytic, neuromuscular, p h o to se n s itiz a tio n )  
presumably a r i s e  from common underly ing  mechanisms, th e  to x ic  e f fe c ts  
perhaps being aggravated by an environmental o r  g en e tic  p re d isp o s itio n .
Three basic  ways in  which the  phenothiazine molecule in te r a c ts  w ith  
th e  c e l lu la r  components o f  t is s u e s  to  produce th ese  observed e f fe c ts  have 
become apparent from ev a lu a tin g  th e  a v a ila b le  l i t e r a t u r e .  These a re  th e  
n o n -sp ec ific  macromolecular d is ru p tio n s  th a t  can occur to  l i p i d  o r  p ro te in  
molecules in  membranes and o th e r lo c a tio n s , th e  form ation o f m etabo lite  
redox systems to  perm it energy t r a n s f e r  to  d is ru p t c e l lu la r  components 
and enzyme systems and th e  form ation o f  a lle rg e n s  w ith  a l l  t h e i r  
immunological sequelae. I t  i s  probable th a t  these  th re e  mechanisms ex p la in  
most, i f  no t a l l ,  o f  th e  ac tio n s  o f  phenoth iazine.
sta tem ent
P a r t  o f the  m a te r ia l included in  th is  th e s is  concerned w ith  th e  
mammalian metabolism o f phenoth iazine has been previously- 
published  in  review form.
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The sy n th es is  o f a mauve s ta in  ( a n i l in e  p u rp le , mauve, 
mauveine, ly r la n  p u rp le ) in  I 856 by W illiam Perkin  and i t s  subsequent 
p roduction  on a te c h n ic a l s c a le  marked the  beginning o f the  *a n i l in e  
dye* in d u stry  o f th e  l a t t e r  h a l f  o f  the  n in e teen th  cen tu ry  The 
value o f  * mauve* was f i r s t  r e a l is e d  in  France in  1859, th e  English  
and S c o ttish  c a lic o  p r in te r s  not showing any in te r e s t  u n t i l  i t  
appeared in  French p a tte rn s ,  although some o f them had undertaken 
t r i a l s  to  p r in t  c lo th  w ith th a t  co lo u r. Contamination o f  a n i l in e  
samples w ith  to lu id in e  (methyl a n i l in e )  le d  to  the  fo r tu i to u s  
d iscovery , two years  l a t e r ,  o f  a n i l in e  red  (magenta, ro s a n i l in e ,  
so lv en t red  41, b a s ic  v io le t  14, C .I . 42510). This compound was 
manufactured by Verguin o f  Lyons and in troduced  in to  commerce under 
the  name o f fu chsine .
These e a rly  experim ents were foreshadowed by those o f Runge 
(1830*s) on the  o x id a tio n  o f a n i l in e  when he noted v arious 
co lo u ra tio n s  and th e  form ation o f  a  b lack  p r e c ip i ta te  which was 
ev en tu a lly  in troduced  in  1863 as  th e  valuab le  pigment A n iline  B lack. 
A fte r th i s  i n i t i a l  impetus an ex ten siv e  search  was made f o r  o th e r  
organic bases capable o f  being ap p lied  to  t e x t i l e  f ib re s  in  a 
s im ila r  fash io n  bu t few were found o f  any value and none o f  th e  
importance o f a n i l in e .
P erk ins 'mauve* was a  sh o r t l iv e d  su ccess . Many o th e r  co lo u rin g  
agents had emerged which were not as  f a s t  as  'mauve* b u t were more 
b r i l l i a n t .  Amongst the  co louring  m atters  produced from the  p roducts 
o f coal t a r  were th e  numerous d e r iv a tiv e s  o f  triphenylm ethane, 
in c lu d in g  a n il in e  b lue  (ac id  b lue 22, C .I . 42755), a n i l in e  v io le t
( c ry s ta l  v io le t ,  g en tian  v io le t ,  basic  v io le t  3 , C .I . 42555) and 
a n i l in e  green (m alach ite  green , b as ic  green 4 , C .I . 42000) d iscovered  
by A.W.Hoffmann and methyl v io le t  (b as ic  v io le t  1 , C .I . 42535) 
sy n th esized  by Charles Lauth in  I 86l ,  a lthough  the  l a t t e r  compound 
was no t p repared  on a  la rg e  s c a le  u n t i l  1867 .
In  1876, in  a  note e n t i t l e d  'S u r une nouvelle c la s se  de m atières  
c o lo ra n te s ' and read  by M.Wurtz a t  th e  French Academy o f Sciences,
L au th 's  experim ents were describ ed  in  which he heated  £-phenylenediam ine 
w ith  su lphur and tre a te d  th e  hydroch lo ric  a c id  so lu tio n  o f th e  re a c tio n  
product w ith  f e r r i c  ch lo rid e  to  o b ta in  a  purp le  dye (L a u th 's  v io le t ,  
th io n in e , C .I . 52000) ( i j  . In  th e  same y ea r H einrich  Caro c a r r ie d  
out a  s im ila r  re a c tio n  w ith  £-am inodim ethylaniline and ob tained  a 
b lue  dye known as methylene b lue (b asic  b lu e  9 , C .I . 52015) (2)
(CH3), ( C H , )3 '2
Cl
In te re s te d  in  th i s  new type o f a r t i f i c i a l  dye and su sp ec tin g  th e  
ex is ten ce  o f a  then  unknown th io n a ted  r in g  system as th e  nucleus o f  
th ese  substances, H einrich August Bernthsen s e t  about system atically - 
in v e s t ig a t in g  t h e i r  com position. During th e  course o f  h is  re se a rc h  
he heated diphenylamine w ith  su lphur a t  250-260°C and ob-tained th e  
p rev io u sly  un repo ited  compound, pheno th iazine , in  40^ y ie ld  He 
l a t e r  proved i t s  s tru c tu re  by a  s e r ie s  o f  e leg an t s tu d ie s  and showed
th a t  L a u th s 's  v io le t  and methylene b lue contained  th i s  nucleus ,
I t  was thus during  the  course o f in v e s tig a tio n s  in to  th e  s tru c tu re  
o f  two popular a r t i f i c i a l  dyes th a t  the  sy n th e s is  and i s o la t io n  o f 
phenoth iazine were f i r s t  rep o rted  in  the  l i t e r a t u r e  by Bernthsen in  
1883
B. PHYSICAL AND CHEMICAL PBOPERTIES
Phenothiazine (2 ) ,  mol. wt I 99 . 26 , was f i r s t  c a lle d
thiodiphenylam ine by Bernthsen because o f  i t s  ro u te  o f s y n th e s is . I t
has a lso  been re fe r re d  to  in  th e  l i t e r a t u r e  as 2 ,3  ;5 , 6-d ib e n z o -l,4 -
th ia z in e , d ib en zo p ara th iaz in e , d ib en zo th iaz in e , 2-d ipheny lene-su lpho-
S  8imide and phen th iazine  * . The numbering system g en e ra lly  a p p lie d  to  
th e  molecule and agreed by th e  lUPAC Commission i s  shown below (^ a ) , 
a lthough  o th e r  systems have been used Q b , 3p)
(3b) (3c)
I t  c r y s t a l l i s e s  from benzene, to lu en e  o r bu tanol to  g ive yellow 
l e a f l e t s  o f  from alcoho l in  the form o f co lo u rle ss  diamond-shaped 
p la te s  which become green-brown on exposure to  a i r .  The c ry s ta ls  
belong to  th e  orthorhombic holohedral c la s s  and c o n ta in  fo u r m olecules 
p e r  u n i t  c e l l  The m elting  p o in t o f  phenoth iazine quoted in  th e
l i t e r a t u r e  v a r ie s  between 180-186°C depending upon th e  p u r ity  o f  the  
sample and the  so lv en t o f  c r y s ta l l i s a t io n ,  the  g e n e ra lly  accep ted  
value fo r  th e  pure compound from to lu en e  being 183.1°G. The le s s  pure 
commercial substance has a  m elting  range from 170-175°C 
A non-toxic green  o x id a tio n  product i s  p resen t in  th e  commercial 
p rep a ra tio n  to  about 1% by weight and can be removed by v ir tu e  o f  i t s  
in s o lu b i l i ty  in  d ie th y l e th e r .  The chem ical n atu re  o f  th i s  dark green 
contam inant i s  thought to  be a  dimer o f  phenoth iazine to g e th e r  w ith  
lo n g e r polymers
Sublim ation o f pure phenoth iazine occurs under reduced p re ssu re
(1 mm Hg) a t  130°C and i t  i s  v o la t i le  w ith  steam. B o iling  p o in ts  a re
quoted as 3?1°C a t  76O mm Hg and a t  290°C fo r  40 mm Hg D ensity  i s  
11given as  1.35  . The compound possesses a  f a in t  b u t b i t t e r  t a s t e ,
being  v i r tu a l ly  in so lu b le  in  w ater and carbon te t r a c h lo r id e .  I t  i s  
only  s l ig h t ly  so lu b le  in  chloroform , e th an o l, petroleum  e th e r  (naphtha, 
b .p . 35-80°C), l ig ro in  (so lv en t naphtha, b .p . 80-130°C) and m ineral 
o i l s  bu t d isso lv e s  f r e e ly  in  ho t a c e t ic  a c id , benzene, d ie th y l e th e r ,  
dim ethyl sulphoxide and most o th e r  o rganic so lv e n ts . The s p e c tra l  
c h a ra c te r is t ic s  o f phenoth iazine a re  summarised in  Table 1 .
Phenothiazine i s  prepared  on a  commercial s c a le  by fu sin g  
diphenylamine w ith  su lphur, a  30^  (by w eight) excess o f  diphenylam ine 
u su a lly  being employed. The a d d itio n  o f 0 .1  to  1.0% by w eight o f  
c a ta ly s ts  such as io d in e , aluminium ch lo rid e  o r o th e r  e le c t ro p h i l ic  
types reduces the  re a c tio n  tem perature req u ired  and in c re a se s  th e  



















CO rv \o  On CO On












































vo lA o  in




0 M rH H  ION,
■S g  g 0^ CO iHE C O
g Cx: (d> 1 ft .C0 -P5 1 E 0
00 rv
5 ^
0 ^  CV]
IN-
0^  00
atmosphere has a lso  been shown to  improve the  p rocess by g iv ing  a 
20p u re r  product , F inal p u r if ic a t io n  i s  u su a lly  a ffo rd ed  by d i s t i l l a t i o n  
o r  sub lim ation  follow ed by washing w ith  carbon te t ra c h lo r id e  ^3,21-23^ 
O ther ro u te s  o f  sy n th es is  o f  phenoth iazine e x is t ,  such as th e  r in g  
c lo su re  o f diam inodiphenylsulphide, th e  th io n a tio n  o f  diphenylamine 
w ith  sodium th io su lp h a te  o r  a rse n ic  pen tasu lp h id e , o r  ftom monoarylamines, 
bu t th ese  ro u te s  a re  u n s a tis fa c to ry  and u su a lly  have very low y ie ld s  
The chemical re a c tio n s  th a t  phenoth iazine can undergo have a l l  
been w ell documented and a re  p resen ted  in  d e ta i l  in  s e v e ra l ex tensive  
review s and s tan d a rd  chem istry  te x ts  8,16,24-28^ These re a c tio n s  can 
be summarised a s ;
1 ) . Aromatic s u b s t i tu t io n .  This i s  com plicated because o f  s id e
re a c tio n s  bu t inc ludes n i t r a t io n  which i s  com paratively easy, a c y la tio n  
which i s  somewhat more d i f f i c u l t  owing to  the  competing re a c tio n  o f  
the n itro g en  ce n tre  and halogénation  which i s  u su a lly  accomplished 
in d i r e c t ly  through th e  su lphoxide as  d i r e c t  ha logénation  may le a d  to  
the  form ation o f  p e rh a lid e s .
2 ) . S u b s titu tio n  on th e  n itro g en  atom. The secondaiy amine group
i s  r e a d i ly  a lk y la te d , a cy la ted  and a ry la te d  and g ives r i s e  to  many 
N -su b stitu ted  p ro d u cts.
3 ) . O xidation. This can occur a t  th e  su lphur atom as w ell a s  th e  
carbon atoms o f  th e  molecule to  g ive s ta b le  and c r y s ta l l i s a b le  
compounds. Phenothiazine amine oxides have been rep o rted  bu t t h e i r  
id e n t i ty  i s  no t a b so lu te ly  proven. The re a c tio n  o f  pheno th iazine  w ith  
hydrogen peroxide o r  halogenated p erac ids g ives r i s e  to  the  su lphoxide, 
pheno th iaz ine-5 -ox ide  (4 ) . The n itro g en  atom has to  be p ro te c te d  i f  
th e  sulphone, p h en o th iaz in e-5 , 5-d iox ide  (2 ) ,  i s  re q u ire d  by potassium  
permanganate o x id a tio n .
H
I
( 4 ) ( 5 )
Treatment w ith  FeCl^ w i l l  produce phenothiazone, phenothiaz-3-one ( 6 ) ,  
and fu r th e r  o x id a tio n  o f  the phenothiazone w ith  gives th io n o l,
7-hydroxyphenothiaz-3-one ( j ) .  Both o f  th e  l a t t e r  d e r iv a tiv e s  a re  
co loured  because they possess a  para-quinonoid  type s tru c tu re  and can 
be reduced to  t h e i r  c o lo u r le ss  hydroxy d e r iv a tiv e s  ( 8 ,£ )  w ith  Zn/NB^OH,
A /
2 H " +  2 e -
/ V







4 ) .  D esulphuration. This can be c a r r ie d  ou t w ith  a  v a r ie ty  o f
reag en ts  in c lu d in g  hydroiodic a c id  o r  powdered copper and i s  u se fu l 
in  th e  de term ination  o f  phenoth iazine s tru c tu r e s ,
3)« M eta la tion . With b u ty l lith iu m  th i s  occurs in  the  p o s it io n
a d jacen t to  th e  h e te ro c y c lic  atom (N) o f  th e  r in g ,
6 ) , A ddition to  a c tiv a te d  double bond. Phenothiazine undergoes
a d d itio n  to  v in y l cyanide ( GH^ =GHCN) in  th e  presence o f  a  b as ic  
c a ta ly s t .
We s h a l l  only pursue those  chem ical re a c tio n s  o f  phenoth iazine  
in  so f a r  as  they  r e la te  to  th e  metabolism and l i k e ly  mode o f  b io lo g ic a l 
a c tio n  o f th e  compound.
C. USES AND APPLICATIONS
l ) . In s e c t ic id a l  a c t iv i ty .
For some 50 years a f t e r  i t s  sy n th e s is  pheno th iazine  rem ained 
a  chemical c u r io s i ty .  I t  was an in te r e s t in g  r e s u l t  o f  sy stem atic  
chemical re sea rch  and provided th e  nucleus fo r  th e  development o f  
o th e r  a r t i f i c i a l  dyes and b io lo g ic a lly  a c tiv e  compounds. Indeed, i t  
was and s t i l l  i s  th e  p a ren t compound o f  a  m ultitude o f  drugs which 
have found v a ried  and ex ten siv e  use in  c l in ic a l  p r a c t ic e .  Methylene 
b lue was in v e s tig a te d  as  an an a lg es ic  in  I 89O and was used a s  th e  
sy n th e tic  a n t im s la r ia l  agent ^ . In  the  1930*s th e  discovezy 
o f  chloiprom azine and the  subsequent renewed in t e r e s t  in  N -su b s titu te d  
phenoth iazines provided a  h o s t o f  new pharm acologically  a c t iv e  
compounds. By th e  e a r ly  1970 's  over 3 ,000 phenoth iazine  d e r iv a tiv e s  
had been syn th esized  and a t  l e a s t  one hundred o f them have been in  
c l in i c a l  use as t r a n q u i l l i s e r s ,  an tih is ta m in es , a n tie m e tic s , s e d a tiv e s , 
an a lg es ic s  and agen ts fo r  th e  trea tm en t o f  Parkinsonism
However, i t  was not u n t i l  1934 th a t  phenoth iazine i t s e l f  was
shown to  possess any u se fu l b io lo g ic a l p ro p e r tie s .  In  an e a r ly  re p o r t
32by F.L.Campbell and coworkers s ix ty -e ig h t  compounds co n ta in in g  
su lphur were compared to  n ic o tin e  fo r  t h e i r  to x ic i ty  to  c u lic in e  
mosquito la rv a e . Twenty-four o f th ese  compounds were found to  be equal 
to  o r  exceed n ic o tin e  in  to x ic i ty  and phenoth iazine was shown to  be 
even more to x ic  than  rotenone, being e f fe c t iv e  a t  co n cen tra tio n s  as 
low as  1 ppm. S h o rtly  afte rw ards I.E .S m ith  and co lleag u es dem onstrated 
i t s  high to x ic i ty  to  newly hatched cod ling  moth (apple  maggot) la rv a e . 
This le d  to  ex ten s iv e  orchard t r i a l s  and as a  r e s u l t  i t  was f re q u e n tly  
used as  a  f r u i t  sp ray  in s te a d  o f  le a d  a rsen a te  to  c o n tro l th i s  p e s t.
I t  was fu r th e r  shown not to  a f f e c t  the  q u a l i ty  o f  o r  to  leave  a  to x ic  
re s id u e  on th e  f r u i t  and was harm less to  the fo lia g e . In  a d d itio n , i t  
was n o ticed  th a t  th e  sprayed f r u i t s  d id  not become in fe c te d  o r  decay 
as ra p id ly  as unsprayed produce when s to re d  and a  s l i g h t  fu n g ic id a l 
a c t iv i ty  was a t t r ib u te d  to  phenothiazone ( 6 ) .  This i s  a  carbon o x id a tio n  
product o f phenoth iazine formed under s u ita b le  w eathering  c o n d itio n s , 
i t s  p roduction  being  a c c e le ra te d  in  th e  m ixtures o f  pheno th iaz ine , 
b en to n ite  and lim e which were used to  f a c i l i t a t e  th e  ease  o f  sp ray ing  
th is  in so lu b le  compound
î^u^ther t r i a l s  o f  th e  in s e c t ic id a l  p ro p e r tie s  o f  pheno th iazine
showed th a t  i t  possessed  v a r ia b le  potency to  many sp e c ie s . As w ell as
being le th a l  by c o n ta c t to  th e  newly hatched codling  moth and mosquito
la rv ae  i t  was a lso  to x ic  to  th e  Mexican bean b e e t le ,  European com
b o re r, lim a bean pod b o re r, grape b erry  moth, tomato pinworm and screw 
l 6 36
worms ' . I t  was shown to  a c t  as  a  stomach poison f o r  th e  silkworm
and th e  te n t  c a t e r p i l l a r  bu t had l i t t l e  e f f e c t  a g a in s t th e  cabbage worm, 
grasshopper, com  e a r  worm, Japanese b e e tle ,  tomato f r u i t  worm, plum 
c u rc u lio , tobacco hookworm o r  th e  b o ll  w eevil P henoth iazine
in  f r u i t  sp rays has a lso  been shown to  favour th e  development o f
37s p id e r  mite populations . The American cockroach was not a f fe c te d
when fed  phenoth iazine bu t succumbed when i t  was ap p lied  to  the
O D
c u t ic le  . In a d d itio n , honey bees could in g e s t as much as  57O ug
27 39w ithout any apparen t to x ic  e f f e c ts  ,
2 ) . A n tib a c te r ia l a c t iv i ty .
I t  was n o ticed  th a t  th e  u rin e  from r a t s  rece iv in g  o ra l
phenoth iazine tu rned  red  on exposure to  a i r  bu t d id  no t develop th e
usual o ffen s iv e  odour on s tan d in g . Subsequent exam ination revealed
the  la ck  o f  gross evidence o f  b a c te r ia l  growth in  the u r in e  a f t e r
4ostan d in g  exposed f o r  sev e ra l weeks . P re lim inary  t e s t s  showed th a t
a  re ta rd a t io n  in  th e  growth o f  E scherich ia  c o l i  added to  th e  u rin e
o f  r a t s ,  r a b b its  and a  human p rev io u sly  fed w ith  phenoth iazine
occurred  a f t e r  incubation  f o r  24 hours when compared to  a d d itio n s  to
normal u rin e  from u n tre a ted  anim als, suggesting  an a n t is e p t ic  a c tio n
o f phenoth iazine o r  i t s  m e tab o lite s . Thionol (%), a  u r in a ry  m etab o lite
o f  phenoth iazine, was a lso  shown to  possess a  b a c te r io c id a l  a c tio n
a g a in s t Staphylococcus aureus in  v i t ro
F u rth er in v e s tig a tio n s  showed th a t  th e  o ra l a d m in is tra tio n  o f
phenoth iazine brought about some improvement o f experim en ta lly  induced
c y s t i t i s  (E .o o li)  in  male r a b b i ts .  T ests  in  humans w ith  both chron ic
and acu te  u r in a ry  t r a c t  in fe c tio n s  showed th a t  I 5 p a t ie n ts  (5  ch ron ic ,
10 acu te )  were c l in ic a l ly  cured and th a t  only 8 ou t th e  4p f a i l e d  to
secu re  r e l i e f  from symptoms o f  the u r in a ry  t r a c t  inflam m ation
42fo llow ing  phenoth iazine therapy
In v e s tig a tio n s  in to  th e  n a tu re  o f  th e  b a c te r io c id a l  a c t io n  o f  
phenoth iazine in d ic a te d  th a t  i t  was no t a  p ro p erty  o f  th e  p a re n t 
compound bu t o f  i t s  o x id a tio n  product, th io n o l ^ . In te re s t in g ly ,  
phenoth iazine i t s e l f  has been shown to  in h ib i t  th e  growth o f  tu b e rc le
b a c i l l i  in  v i t ro  in  high d i lu t io n  ( l  ppm), the  b a c te r io s ta t ic  e f f e c t  
being  dim inished in  th e  presence o f  serum but s t i l l  s ig n if ic a n t ,  
whereas th e  o x id ised  forms o f phenoth iazine only showed a  moderate 
degree o f in h ib i t io n  (10 ppm)
3 ) . A nthelm intic a c t iv i ty .
In 1938 phenoth iazine was rep o rted  to  be e f fe c t iv e  in  p reven ting  
th e  development o f horn f l y  la rv ae  in  th e  faeces o f  c a t t l e  p rev io u sly
44-46tre a te d  w ith  o ra l doses o f  th i s  compound . About th e  same tim e
a t r i a l  was c a r r ie d  out by E .L .Taylor and K.M,Sanderson on p igs
in fe c te d  w ith  a s c a r is  a t  the v e te r in a ry  lab o ra to ry  o f  th e  M in istry  of
47A g ricu ltu re , bu t no d e f in i te  conclusions were a r r iv e d  a t  . However,
P.D.Harwood and co lleagues a t  th e  Bureau o f  Animal In d u stry  managed
to  dem onstrate a  r a th e r  v a ria b le  bu t n ev erth e less  marked a c tio n  o f
48the  compound in  removing a sc a rid s  and nodular worms from swine
In  1939 th e  compound was found by s e v e ra l workers in  A u s tra lia  and
Canada to  be e f fe c tiv e  a g a in s t s tro n g y lo id  worms in  sheep and th i s
was a fte rw ard s confirmed by Taylor and Sanderson fo r  the A.B.C. in  
47 4qEngland ' A fte r th ese  i n i t i a l  in v e s tig a tio n s  many more 
dem onstrations o f  th e  an th e lm in tic  euztiv ity  o f  phenoth iazine were 
p resen ted  and th ese  have been subsequently  more than  adequate ly  
reviewed in  th e  l i t e r a t u r e
For a  time phenoth iazine was viewed as a  panacea f o r  p a r a s i t i c  
in fe c t io n s .  The use o f th e  compound to  c o n tro l l iv e s to c k  p a r a s i te s ,  
w ith  i t s  powerful in d i r e c t  e f f e c t  on human h e a lth , overshadowed i t s  
o th e r  v a lu es . In  th e  U nited S ta te s  th e  p roduction  o f  pheno th iazine  
ro se  from 408 kg in  1939 to  1 ,260,300 kg in  1943, la rg e ly  f o r  
an th e lm in tic  consumption. In 1946 th e  U.S. p roduction  was es tim ated  
a t  1 , 788,200 kg I t  has been c i te d  th a t  between December 1938
and January 1944 approxim ately 9OO a r t i c l e s  had appeared on th e  use
48o f phenoth iazine as an an th e lm in tic  . Folse, in  h is  comprehensive 
review , accounted f o r  about 400 o f th ese , perhaps in d ic a tin g  the
av id  in t e r e s t  o f  in d u s try  and th a t  many o f th ese  a r t i c l e s  were in te rn a l
53p u b lic a tio n s  . The same au th o r l i s t e d  over 1,500 p u b lic a tio n s  
concerning phenoth iazine which had appeared in  th e  world l i t e r a t u r e  
between 1934 and I 958 and dem onstrated a  ra p id  in c rease  during  the 
e a r ly  1940*s. I t  was during th is  p e rio d  th a t  the use o f phenoth iazine 
a g a in s t sheep p a ra s i te s  was estim ated  as p rev en tin g  an annual lo s s  o f 
one m illio n  d o lla rs  in  th e  S ta te  o f  Kentucky a lone
The compound was used ex te n s iv e ly  in  rum inants throughout the 
world fo r  some 20 years a f t e r  i t s  in tro d u c tio n  and, a lthough s t i l l  
used on a  sm all sc a le  as  a  cheaper form o f therapy  and as a 
p ro p h y lac tic  in  the co n tro l o f manure-breeding f l i e s ,  i t  e f f e c t iv e ly  
d isappeared from th e  farm ing scene in  th e  mid-1960 's  being superseded 
by more e f f i c i e n t  and s a f e r  broad spectrum a n th e lm in tic s , such as  
th iabendazo le . However, during th e  period  o f  i t s  w idespread p o p u la rity  
many m illio n s  o f anim als were su c c e ss fu lly  t r e a te d  w ith  pheno th ia ine  
a t  dosage r a te s  th a t  may be considered  la rg e  when compared w ith  
modem an th e lm in tic s  ( ik b le  2 ) .  I t  was th i s  a v a i l a b i l i ty  o f  
c o u n tle ss  numbers o f  anim als coupled w ith  th e  wide f in a n c ia l  and 
s c ie n t i f i c  in t e r e s t  in  th e  drug th a t  provided th e  o p p o rtu n ity  and th e  
in c en tiv e  to  in v e s tig a te  th e  compound in  d e ta i l  and th u s  g ive 
s u f f ic ie n t  in form ation  to  c o n s tru c t an o v e ra ll  p ic tu re  o f  th e  
mammalian metabolism o f  th is  an th e lm in tic  and to  perm it an in s ig h t  
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2 . METABOLISM AND DISPOSITION
A. METABOLISM
Phenothiazine Q ) ,  l ik e  many o th e r fo re ig n  compounds, 
undergoes chem ical m od ifica tion  during  i t s  passage through th e  
mammalian body before being expelled  in to  the  environment. S yn thetic  
(con jugation) reac tio n s  w ith  endogenous s u b s tra te s ,  r e s u l t in g  in  the 
form ation o f more p o la r  and w a te r-so lu b le  condensation p ro d u c ts , can 
occur e i th e r  d i r e c t ly  w ith  a drug o r  a f t e r  a  r e a c tiv e  s i t e  has been 
in troduced  by m od ifica tion . Such a l te r a t io n s  can take th e  form o f 
o x id a tio n , reduction  o r  h y d ro ly s is . Phenothiazine only e x h ib its  
o x id a tio n .
l ) . O xidation.
As i l l u s t r a t e d  in  Scheme 1 , C -oxidation occurs para to  th e
n itro g en  atom in  the  h e te ro cy c lic  s tr u c tu re  to  g ive  leucophenothiazone
(3 -hydroxyphenothiazine)( 8 ) and leu co th io n o l (3 , 7-dihydoxyphenothiazine)
(£ ) . ihese phenolic d e r iv a tiv e s  may be f u r th e r  o x id ised , e s p e c ia lly
on exposure to  th e  atm osphere, to  y ie ld  the  corresponding co loured
qu ino id  s tru c tu r e s ,  phenothiazone ( 6 ) and th io n o l (£) re sp e c tiv e ly .
S-Q xidation g ives phenoth iazine su lphoxide (4) which i s  excre ted
unchanged and th e re  i s  no evidence th a t  i t  i s  m etabolised  f u r th e r  to
the  sulphone (£ ) o r  ex cre ted  in  a  con jugated  form although  i t  may
undergo fu r th e r  in te rco n v ers io n s  m  v iv o . Ihe form ation o f  amine oxides
(10 , 11) has been rep o rted  to  occur during  in cu b atio n  o f guinea p ig
l i v e r  microsomes w ith  phenoth iazine ^  b u t in  vivo s tu d ie s  have f a i le d
55to  show any N -oxidation products and recen t re p o r ts  suggest th a t  
those p rev iously  id e n t i f ie d  were in  f a c t  G -oxidation compounds
p h e n o t h i a z i n e  - N - g lucuronide
t
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p h e n o t h i a z i n e
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thionol  g l ucu ron ide  l e u c o t h i o n o l  g l u c u r o n i d e
Scheme 1 . The mammalian metabolism o f  pheno th iaz ine .
O - O H
(11)
2 ) , Gon.iugation.
Leucophenothiazone i s  conjugated  w ith  su lp h u ric  a c id  to  give
the  c o lo u rle ss  leucophenothiazone su lp h a te , w h ils t  le u c o th io n o l/th io n o l
conjugates w ith  g lucuron ic ac id  to  form an e th e r  g lucuronide which
may e x is t  as e i th e r  th e  c o lo u rle ss  leu co th io n o l conjugate o r  th io n o l
glucuronide co n ta in in g  the  co loured  phenothiazone moiety (Scheme l ) .
I t  i s  probable th a t  th e  two s tru c tu re s  a re  e a s i ly  in te rc o n v e r tib le
and th a t  the  g lucuronide i s  e i th e r  i n i t i a l l y  excreted  in  th e  coloured
quinoid  form o r th a t  i t  i s  ra p id ly  ox id ised  on co n tac t w ith  the a i r  
£-0
a f t e r  ex c re tio n  , D irec t con jugation  o f phenoth iazine w ithout p rev ious 
o x ida tion  i s  p o ss ib le  and has been o ften  re p o rte d  in  th e  l i t e r a t u r e  
as a ’w ate r-so lu b le  a c id - la b i le  conjugate o f  phenoth iazine * re c e n tly  
been given th e  assignm ent o f an N -glucuronide .
A po lypeptide conjugate o f phenoth iazine co n ta in in g  a t  l e a s t  
s ix  amino ac id s  in c lu d in g  a rg in in e , glutam ic a c id , phenyla lan ine  and 
ty ro s in e  has a lso  been observed in  th e  u rin e  o f ca lves up to  s ix  weeks 
o ld  More re c e n t in v e s tig a tio n s  have shown th a t  a  po lypeptide
conjugate f ra c t io n , accounting f o r  about 3% o f the  adm in istered  dose,
could be iso la te d  from the  u rin e  o f th ree  day o ld  male F r ie s ia n  ca lves 
a f t e r  trea tm en t w ith  p h en o th iaz in e . Ih is  f ra c t io n  co n s is ted  o f fo u r 
d i f f e r e n t  po lypeptide conjugates con ta in ing  two, th re e , f iv e  and s ix  
amino a c id s  re sp e c tiv e ly , a tta ch ed  to  th e  n itro g en  atom o f  phenoth iazine 
o r leucophenothiazone by means o f th e  carboxyl te rm inal o f  th e  p ep tid e  
chain  (F ig . l )
3 ) . Ring degradation .
Although i t  has been rep o rted  th a t  about 10^ o f  a  dose o f
or
( S )-phenoth iazine given to  dogs was ex cre ted  in  th e  u r in e  as la b e l le d
ino rgan ic  su lphate  which could be p re c ip i ta te d  w ith  barium ch lo rid e  ,
i t  has re c e n tly  been found th a t  both  ino rgan ic  su lphate  and
leucophenothiazone su lp h a te  were p re c ip i ta te d  by barium ch lo rid e  from
3 5the  u rin e  o f  guinea p ig s  dosed w ith  ( S ) -p h en o th iaz in e . Subsequent 
chromatography showed th a t  th e  ra d io la b e l was s t i l l  a s so c ia te d  w ith  
th e  phenoth iazine nucleus. In  a d d itio n , anim als fed  ( ) -phenothiazine 
d id  no t ex p ire  any ra d io a c tiv e  carbon d iox ide  in d ic a tin g  th a t  the  r in g  
s tru c tu re  was not degraded du ring  i t s  passage through th e  guinea p ig  
body
4 ) .  B io transform ation  o f  phenoth iazine m etab o lite s .
Experiments w ith  sheep, r a b b its  and guinea p igs have shown th a t  
o ra l ly  adm in istered  phenoth iazine sulphoxide i s  e lim in a ted  in  th e  u rin e  
as both  phenoth iazine and phenothiazone b u t no t in  th e  unchanged form, 
the  sulphoxide i t s e l f  being d e te c ta b le  only in  the  fa e c e s . Dosing w ith  
phenothiazone o r th io n o l only le a d s  to  th e  ex c re tio n  o f th e  compounds 
them selves, e i th e r  f re e  o r  con jugated , and th e re  i s  no evidence th a t  
the  C -oxidation m etab o lites  undergo in  vivo conversion to  phenoth iazine 
o r  i t s  sulphoxide ( ik b le  3 )
N —  gluS  —  glu —  NH2
Q
S N —  g l y   p r o  gly —  NH2
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Phenothiazine and phenothiazone a re  known to  be in te rc o n v e r tib le
66in  s tro n g  ac id  s o lu tio n  and a  ro u te  has been proposed fo r  th e  
o x id a tio n  o f phenoth iazine (Scheme 2) This sequence proceeds
v ia  e le c tro n  and proton removal to  give the  phenazothionium ion , the  
most s ta b le  resonance form o f  which i s  shown. Another resonance form 
i s  th e  3 -carbonium ion  and a t ta c k  a t  G-3 r e s u l t s  in  th e  form ation o f 
leucophenothiazone as  a  s ta b le  end p roduct. The subsequent p roduction  
o f leucophenothiazone su lp h a te  i s  e s s e n t ia l ly  an i r r e v e r s ib le  p ro c e ss . 
Phenothiazine su lphoxide, however, has been shown to  be in  equ ilib rium  
w ith  th e  phenazothionium ion  ih is  p o s tu la te d  mechanism appears
to  be in  agreement w ith  experim ental observ a tio n  and p lac e s  th e  form ation 
of th e  sulphoxide on a  spur l in e  in  the  bio  tran sfo rm atio n  ro u te  and 
not in  th e  d i r e c t  ro le  as an a c t iv e  in te rm ed ia te  in  metabolism. I t  i s  
p o ss ib le  th a t  the  tran sfo rm atio n  o f the  phenazothionium ion  to  
leucophenothiazone i s  r a te - l im i t in g  in  which case th e  competing 
sulphoxide form ation, which i s  re v e rs ib le ,  a c ts  as a  temporary 
r e s e rv o ir  fo r  phenazothionium io n s .
5 ) .  Conclusions.
Very l i t t l e  5^ v i t ro  work has been c a r r ie d  ou t on th e  metabolism 
o f phenoth iazine i t s e l f  mainly because o f  i t s  low w ater s o lu b i l i ty .  
However, incubations o f phenoth iazine w ith  guinea p ig  l i v e r  homogenates 
and microsomes derived  from ham ster l i v e r  have dem onstrated the form ation  
o f phenoth iazine sulphoxide to g e th e r  w ith  the  carbon o x id a tio n  
products I t  i s  presumed th a t  pheno th iazine , by analogy w ith
in v e s tig a tio n s  u sin g  the  w ater so lub le  N -su b s titu ted  d e r iv a tiv e s  o f  
phenoth iazine, notab ly  chlorprom azine o x id ised  by a  microsomal
cytochrome P -4^0-contain ing  monooxygenase system m ainly w ith in  th e  
l i v e r ,  although th ese  o x id a tio n  re a c tio n s  may w ell occur a t  o th e r  s i t e s  
such as  w ith in  th e  mucosa o f th e  sm all in te s t in e .  Indeed, th e  o r a l
p h e n o th i a z in e
p h e n o th i a z in e  s u lp h o x id e
v ia  î e m i q u in o n e  
f o r m s
2 e ' + H
O H "
+
p h e n a z o th io n iu m  ion  
/K
r e s o n a n c e
3 - c a r b o n i ü m  ion
S "  ' O H
le u c o p h e n o th ia z o n e
p h e n o t h i a z o n e
le u c o p h e n o t h i a z o n e  s u l p h a t e  
th io n o l
th io n o l  q lu cu ro n id e
Scheme 2. Proposed, scheme o f phenoth iazine o x id a tio n .
Redrawn and s im p lif ie d  a f t e r  Refs. I 5 & 67 ,
p re trea tm en t o f r a t s  w ith  phenoth iazine in  th e  d ie t  f o r  sev e ra l days 
has been shown to  b rin g  about an in d u c tio n  o f cytochrome P-4^0
71mediated microsomal hydroxyla tions in  th e  l i v e r ,  kidney and in te s t in e  * 
The con jugation  o f phenoth iazine and i t s  hydroxylated  m etabo lites  
a lso  presumably takes p lace  in  the l i v e r ,  although th i s  too may occur 
a t  o th e r  s i t e s ,  the  gut w all being a  prime candidate  f o r  su lp h a tio n .
The b a s ic  p a tte rn  o f metabolism, a s  summarised in  Scheme 1 , i s  
the  same fo r  a l l  mammals s tu d ie d  w ith  th e  exception o f  th e  phenothiazone- 
p ep tid e  con jugates from young calves a l t h o u ^  such m etab o lites  may 
e x is t  in  the u r in e  o f o th e r  ra p id ly  developing neonates o f many sp ec ies  
as y e t  u n in v estig a ted  Prom the accum ulated r e s u l t s  o f  u r in a ry  
m etab o lites  a  comparison o f  sp ec ies  can be made, though i t  must be 
remembered th a t  very  few q u a n t i ta t iv e  r e s u l t s  a re  a v a ila b le  and th a t  
f a i lu r e  to  mention the  p resence o f a  m etab o lite  may sim ply in d ic a te  
th a t  i t  was no t sought (Table 4 ) .  For example, Benham has produced 
an e x c e lle n t paper in  which he described  the then-novel m etab o lite , 
th io n o l g lucuron ide , p re se n t in  ra b b it  u rin e  bu t made no mention o f  
th e  N-glucuronide o r unconjugated m etab o lites  d e tec ted  by o th e r  
workers (Table 4 ) .
A ll sp ec ies  s tu d ied  ex cre te  the  m ajo rity  o f  t h e i r  u r in a ry  products 
in  conjugated form (> 80%), predom inantly the  N-glucuronide and 
leucophenothiazone su lp h a te . A b as ic  d iffe re n c e  appears to  l i e  in  
th e  percentage o f  the  drug which undergoes C -oxidation (Table 5) r a th e r  
than  whether o r  not con jugation  occurs w ith  g lucuron ic  o r  su lp h u ric  
a c id  as both o f  th ese  sy n th e tic  re a c tio n s  appear to  be a v a ila b le  in  
n ea rly  a l l  sp ec ie s  (Table 4 ) .  Accurate q u a n ti ta t iv e  d a ta  a re  not 
a v a ila b le  fo r  a l l  sp ec ie s , bu t they  tend  to  f a l l  in to  two groups, 
th o se  in  which C -oxidation appears to  predom inate (dog, horse, sheep, 
cow, ra b b it ,  g e rb i l ,  r a t  and mouse) ev en tu a lly  g iv in g  r i s e  to  
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which i t  accounts f o r  a  th i r d  o r  le s s  o f  th e  u r in a ry  ou tpu t (man, p ig , 
guinea p ig  and ham ster). The l a t e r  group ex cre te  the  m ajo rity  o f  t h e i r  
dose in  th e  form o f phenothiazine-N -glucuronide which may suggest a  
le s s  e f f ic ie n t  microsomal o x id a tio n  system fo r  phenoth iazine in  th ese  
sp e c ie s . However, the  rev erse  s i tu a t io n  may he more probable in  which 
th e  apparen t poor G -oxidation group may have ex ten siv e  glucuronyl 
t ra n s fe ra s e  a c t i v i t y  towards th i s  s u b s tra te  in  th e  g u t w all thereby  
forming r e la t iv e ly  la rg e  amounts o f  th e  N -glucuronide before  th e  
compound reaches th e  l i v e r  and thereby  e f fe c t iv e ly  removing i t  as  a 
s u b s tra te  f o r  subsequent C -oxidation . F u rth e r work needs to  be 
undertaken in  t h i s  a rea  befo re  th is  problem can be reso lv ed .
In  a d d itio n  to  the  sp ec ie s  mentioned p rev io u sly , phenoth iazine 
has been ad m in istered  th e ra p e u tic a lly  to  many o th e r  k inds o f anim als 
in c lu d in g  the b e a r  (p o la r  & b r o w n ) b e a v e r  bison®®, camel®^, 
cat^*^, chicken®^’ deei ^^’^^,  e lephan t fox geese 
pheasant ^7*98, pidgeon sa b le  w easel and yak b u t 
veiy  l i t t l e  u se fu l m etabolic d a ta  have been c i te d .  Ihe (^-^S )-labelled  
compound has been shown to  be taken  up by nematode p a r a s i te s ,  
desu lp h u ra tio n  o f th e  h e te ro cy c lic  s tru c tu re  no t being dem onstrable
IG*? C O
, and Zukel ^ has s ta te d  th a t  phenoth iazine ev en tu a lly  k i l l s  th e  
cockroach (P e rip la n e ta  am ericana) by th e  accum ulation o f  a  leu co th io n o l 
conjugate in  the haemolymph bu t does no t d e ta i l  i t s  metabolism.
B. ELIMINATION ROUTES
The major ro u te s  o f  e lim in a tio n  o f phenoth iazine and i t s  
d e r iv a tiv e s  from the  mammalian body a re  v ia  the  u rin e  and faeces; 
even so i t  takes se v e ra l days o r  even weeks fo r  n e a r - to ta l  e lim in a tio n  
to  be achieved. Many workers have found low 24 hour u r in a ry  reco v e rie s  
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In  th e  few q u a n ti ta t iv e  s tu d ie s  concerning fa ec a l e x c re tio n  some 8 to  
44% o f the drug was recovered from sheep by th i s  ro u te  over f iv e  days 
84,106^ Faecal ex c re tio n  by o th e r  species was 24 to  29% in  2 .5  days 
from horses 23% during th e  f i r s t  day from cows and 7 . 7% in  24 
hours ( 23 .9% in  7 days) from guinea pigs In  a d d itio n , phenothiazine
108has been shown to  s t i l l  be p re sen t in  sheep fo r  l4  to  I 6 days , in  
ca lves fo r  5 to  15 days and in  humans fo r  6 to  9 days HO ,111 
a d m in is tra tio n  was d iscon tinued ,
1 ) . U rine.
This i s  th e  most im portant ro u te  o f ex c re tio n  fo r  th a t  p a r t  o f  
the dose which has a c tu a lly  en te red  the  mammalian body a f t e r  ab so rp tio n  
as opposed to  th a t  which i s  c a r r ie d  through the  e n te r ic  t r a c t  unabsorbed 
to  be voided in  th e  faeces . I t  i s  a lso  th e  ro u te  th a t  has been most 
ex ten s iv e ly  in v e s tig a te d  and in  which the  g re a te s t  number o f m etab o lites  
have been found. The a v a ila b le  published d a ta  a re  summarised in  a 
se m i-q u an tita tiv e  fash io n  in  Table 4 . The absence o f  a  m etabo lite  in  
the u rin e  may r e f l e c t  i t s  t ru e  absence o r  i t s  presence in  such sm all 
amounts th a t  i t  has gone undetected  o r even th a t  i t  was simply not 
looked fo r .  In s u f f ic ie n t  in fo rm ation  i s  g iven  in  th e  l i t e r a t u r e  to  
determ ine which of th ese  i s  th e  case .
2 ) . F aeces .
Phenothiazine i s  the  only compound th a t  has been p o s it iv e ly  
id e n t i f ie d  as being p resen t in  th e  faeces o f  sheep 80,84,106^ 83^
horses ra b b its  r a ts  and guinea p igs presumably unabsorbed^ 
although tra c e  amounts o f phenothiazone and th io n o l have been found in  
r a t  faeces ^ and phenothiazone and. phenoth iazine sulphoxide in  guinea 
p ig  faeces ,
I t  i s  probable th a t  ox ida tion  products a lso  occur in  th e  faeces
o f the o th e r  anim als examined bu t in  q u a n ti t ie s  too sm all to  be readily-
d e tec ted . Phenothiazone and phenoth iazine sulphoxide have been observed
in  the gut o f  sheep d i s t a l  to  the b i le  duct and ijn vivo and iji v i t ro
experim ents w ith  rumen co n ten ts  have shown th a t  phenoth iazine was not
converted in to  any d e te c ta b le  d e r iv a tiv e s  except f o r  minute tra c e s  o f
84phenothiazone probably a r is in g  from a i r  ox id a tio n  , in d ic a tin g  th a t
5Q 77 112th e  compounds enetered  the e n te r ic  t r a c t  v ia  th e  b i l e  *
8lPhenothiazone has a lso  been d e tec ted  in  the  gut o f  cows and w ith
113th io n o l in  the  gu t of chickens
3 ) ,  B ile .
Phenothiazone, both  in  the fre e  and conjugated forms, has been
rep o rted  in  th e  b i le  o f  sheep to g e th e r  w ith  t ra c e s  o f  th e  sulphoxide
59 64 77bu t no phenoth iazine was d e tec ted  , These r e s u l t s  a re  u n lik e
those  from cows where pheno th iazine , phenothiazone and tra c e s  o f  the
)henothi«
102,113
sulphoxide were p re sen t -^9,^0,81^ Minute amounts o f p o th iaz ine ,
phenothiazone and th io n o l were found in  chicken b i le
phenothiazone and an u n id e n tif ie d  glucuronide (presumably ph en o th iaz in e-
N -glucuronide) in  r a t  b i l e  and phenoth iazine-N -glucuronide was
p resen t in  th e  b i l e  from guinea p ig s  to g e th e r  w ith  tra c e  amounts o f
phenoth iazine probably from th e  breakdown o f the  conjugate
P henothiazine, leu co th io n o l and th io n o l were id e n t i f ie d  in  th e  b i le
from r a b b i ts , dogs and a  human su b je c t bu t th e  d e te c tio n  methods used
d id  not perm it the d i f f e r e n t ia t io n  between phenoth iazine and i t s
73N-glucuronide o r between the C -oxidation  products .
O verall b i l i a r y  s e c re tio n  seems to  account f o r  only a  few p ercen t 
o f  the  adm in istered  dose (eg . 2 .?% dose in  0 to  24 hour guinea p ig  
b i l e  and i s  not a  major ro u te  o f  e lim in a tio n  o f  th e  drug.
4 ) .  Milk.
A pink d isc o lo u ra tio n  occurring  a f t e r  exposure to  a i r  f o r  sev e ra l 
hours was n o ticed  w ith  goat milk H 4 ,1 1 5  cow m ilk c o lle c te d
from anim als t r e a te d  w ith  pheno th iazine . Such cow m ilk gave a  mauve 
co lo u r upon a d d itio n  o f concen tra ted  hydroch loric  a c id  th e  pink
chromogen being id e n t i f ie d  as a  phenothiazone d e r iv a tiv e  S im ila r 
ob servations have been made w ith  sheep m ilk where leucophenothiazone 
and i t s  su lp h a te  conjugate have been id e n t i f ie d  ^9 »80^
5 ) .  Blood.
The phenoth iazine d e r iv a tiv e s  id e n t i f ie d  in  th e  bloodstream  o f 
the  f iv e  sp ec ies  th a t  have been s tu d ie d  a re  shown in  Table 7. 
U n d iffe ren tia ted  r a d io a c t iv i ty  has a lso  been found in  th e  b lood o f 
ham sters a f t e r  in tra p e r i to n e a l  dosage o f  (^-^S)-phenothiazine 
G lare has s ta te d  th a t  d iffe re n c e s  may be observed depending on where 
the blood i s  sampled and has shown th a t  in  sheep th e  p o r ta l  blood 
contained  both  phenothiazone and the  sulphoxide whereas th a t  in  th e  
system ic c ir c u la t io n  con tained  only phenothiazone ,
C o llie r  found th a t  haemolysed e ry th ro cy tes  from sheep t r e a te d
w ith  phenothiazine con tained  no leucophenothiazone su lp h a te  a lthough
80i t  was p re sen t in  th e  serum and i t  has a lso  been shown th a t  
phenoth iazine does not p e n e tra te  e ry th ro cy te s  from th e  plasma 
In agreement w ith  th is  f in d in g  the  2.,^ % o r  so o f  th e  t o t a l  r a d io a c t iv i ty  
p re se n t in  th e  c e l l  f r a c t io n  o f  guinea p ig  blood was shown to  be 
asso c ia ted  w ith  th e i r  membranes and no t t h e i r  c o n te n ts , in d ic a t in g  
ad so rp tio n  to  the  e ry th ro cy te  su rface  bu t no passage in to  th e  c e l l  
This presumably r e f le c t s  the sim ple p a r t i t io n  o f phenoth iazine between 
l i p i d  and aqueous phases w ith  th e  compound being much more s o lu b le  in  
o rganic m a te r ia l. In a d d itio n , when phenoth iazine (2 .5  x 10""%) was 
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approxim ately h a l f  o f the  compound was found to  be bound to  the  c e l l s  
120 . Phenothiazone and th io n o l have a lso  been shown to  bind to  bovine 
serum albumin (a lso  y eas t n u c le ic  ac id  and c a l f  thymus nucleohistone) 
bu t i t  was found th a t  th i s  b ind ing , a lthough  m oderately s tro n g , was 
not ex ten siv e  w ith  only two b ind ing  s i t e s  being a v a ila b le  p er mole o f 
albumin p ro te in  ( c f .  methyl orange which has 22). However, owing to  
th e  low aqueous s o lu b i l i ty  o f  th ese  m etab o lites  a l l  th e  p o te n tia l  
b ind ing  s i t e s  may not have been sa tu ra te d  w ith  the  compounds
6) .  O ther ro u te s .
M etabolic s tu d ie s  using  (^^C)-homocyclic r in g  la b e l le d  phenoth iazine 
in  the  guinea p ig  showed th a t  no d e te c ta b le  r a d io a c t iv i ty  was exp ired  
during  the th ree  days a f t e r  dosing in d ic a tin g  th a t  pulmonary ex c re tio n  
was no t a  s ig n i f ic a n t  ro u te  o f  e lim in a tio n  S im ila r  conclusions were 
drawn from work w ith  cows
In v e s tig a tio n s  in to  th e  a e tio lo g y  o f  p h o to sen s itiz ed  k e r a t i t i s
(see l a t e r )  o ccu rrin g  in  phenoth iazine t r e a te d  anim als le d  to  th e
d iscovery  of phenoth iazine su lphoxide, b u t no o th e r  d e r iv a tiv e , in  the
aqueous humour o f ca lves and o ccas io n a lly  in  sheep th a t  were t r e a te d
w ith  h i ^  doses -^9,122^ N onspecific experim ents u sing  (®-^S)-phenothiazine
have shown th a t  r a d io a c t iv i ty  was p re se n t in  the  uveal t r a c t  o f  hamsters
and ra b b its  bu t in  in s ig n if ic a n t  amounts when compared w ith  th e  uptake
118of N -su b stitu ted  phenoth iazines . Phenoth iazine sulphoxide has a lso  
been found in  th e  lac rim a l f lu id  o f  young calves . S tud ies w ith  c a ts ,  
monkeys and humans have shown th a t  t h i s  ra d io a c tiv e  phenoth iazine i s  
s e le c t iv e ly  taken up hy d i f f e r e n t  p a r ts  o f  the  b ra in , p a r t ic u la r ly  th e  
stem,- and th a t  th i s  s p e c if ic  d is t r ib u t io n  could no t be accounted 
fo r  s o le ly  by th e  d en s ity  o f v a sc u la r  t is s u e  p re se n t I t  i s  presumed 
th a t  th e  compounds a re  tra n sp o rted  to  the l ip id - r i c h  neuronal a reas  o f 
th e  uveal t r a c t  and b ra in  by th e  bloodstream  and then  p r e f e r e n t ia l ly
e n te r  th ese  a re a s , gain ing  access through th e  KLood-brain b a r r ie r  simply 
because o f  t h e i r  h igh l i p id  s o lu b i l i t i e s .
During th e  trea tm en t o f pregnant goats w ith  phenoth iazine i t  was 
n o ticed  th a t  a f t e r  p a r tu r i t io n  the  e n t i re  integum ent o f  th e  w hite k id s 
was s ta in e d  pink, suggesting  e x c re tio n  o f C -oxidation products in to  the 
am niotic f lu id  b a th in g  the  fo e tu s  in  u te ro  Blood ob tained  from th e  
fo e tu s  o f a p regnant ewe con tained  no d e te c ta b le  leucophenothiazone 
in d ic a tin g  th a t  i t  d id  not pass ac ro ss  the  p lacen ta
7 ). C onclusions.
In  g e n e ra l, phenoth iazine i s  poorly  absorbed from the  g a s tro ­
in te s t i n a l  t r a c t  a f t e r  o ra l a d m in is tra tio n . However, enough m a te ria l 
o f th e  la rg e  th e rap eu tic  dose i s  absorbed in to  th e  bloodstream  and 
d is t r ib u te d  throughout th e  body to  cause to x ic  e f f e c t s .  This wide 
d is t r ib u t io n  throughout the  t is s u e s  has been dem onstrated during  
postmortem exam ination o f  p h e n o th ia z in e -tre a te d  c a t t l e  in  which the
C -oxidation products were found in  the  l i v e r ,  sp leen  and m esenteric 
8llymph nodes , w hile a f t e r  a  prolonged exposure to  th e  a i r  the  whole 
c a rcass  took on a  red  co lo u ra tio n  R adioactive phenoth iazine  has 
a lso  been shown to  c ross  th e  b lood-b ra in  b a r r ie r  I t  i s  t h i s  
wide d is t r ib u t io n  to g e th e r w ith  i t s  low aqueous s o lu b i l i ty  -  high l i p i d  
s o lu b i l i ty  and p ro te in  b ind ing  which le a d s  to  i t s  prolonged re te n t io n  
in  th e  mammalian body.
C. PHARMACOKINETICS
D isappoin ting ly  l i t t l e  pharm acokinetic d a ta  can be deduced 
from the l i t e r a t u r e  because most published  r e s u l t s  a re  incom plete, not 
possessing  s u f f ic ie n t  d e ta i l  and lack in g  s p e c i f ic i ty  in  q u a n ti ta t iv e  
m etabolite  d e term ina tions. For example, the e a r l i e r  papers measured
t o t a l  drug ou tpu t by o x id a tio n  o f  th e  p a ren t compound and a l l
m etabo lites  in c lu d in g  conjugates to  phenothiazone o r  a  bromine
d e r iv a tiv e  o f th io n o l, both o f  which were h ig h ly  coloured and
76 79 124e a s i ly  q u a n tita te d  by sim ple co lo rim e tr ic  methods . O ther
workers only recorded  values f o r  the f i r s t  few hours a f t e r  dosing o r 
a  s in g le  u rin e  c o l le c t io n  o f  0 to  24 hours thus g iv ing  only one o r  
two d a ta  p o in ts  and making any pharm acokinetic a n a ly s is  im possib le.
N evertheless, cum ulative u rin a ry  ex c re tio n  curves can be
co n stru c ted  fo r  man, horse and sheep (F ig . 2 ) , These p lo ts  in d ic a te
th a t  th e  l a r g e s t  amount o f  drug i s  ex cre ted  w ith in  th e  f i r s t  24 hours
a f t e r  dosing and th a t  th e  f a s t e s t  r a te  o f ex c re tio n  (mg h r  occurred
in  th e  0 to  9 hour period  in  man, horse, sheep and cow ^^*7^^79, 81 , 125^
A more d e ta ile d  exam ination o f  th e  ex c re tio n  r a te s  in  horse and sheep
(Table 8 ) shows a  maximum in  th e  4 .0  to  7 .5  hour p e rio d  follow ed by a
second in c rease  during  th e  12 .0  to  31 «5 hour c o l le c t io n  p e rio d s . This
could p o ssib ly  r e f l e c t  reab so rp tio n  a f t e r  b i l i a iy  s e c re t io n , a  s im ila r
125p a tte rn  being observed during s tu d ie s  w ith  a  human v o lu n tee r  ^
However, t h i s  phenomenon was not observed f o r  a l l  anim als s tu d ie d  7^,79 
although th i s  may have been due to  in a p p ro p ria te  c o l le c t io n  p e rio d s .
A few in v e s tig a tio n s  have been undertaken where the drug 
co n cen tra tio n  in  s e r i a l  blood samples has been m onitored and th e  
r e s u l t s  a re  shown c o l le c t iv e ly  in  F ig . 3 . % e sheep i s  th e  anim al in  
which th e  m ajo rity  o f the rep o rted  s tu d ie s  have been performed and i t  
can be seen th a t  values r i s e  to  a  maximum w ith in  th e  f i r s t  n ine  hours 
a f t e r  dosing and then slow ly d e c lin e , s t i l l  being d e te c ta b le  in  some 
anim als a f t e r  72 hours. One animal (C) shows a  peak value a t  24 hours 
although th i s  anomaly i s  alm ost c e r ta in ly  due to  in s u f f ic ie n t  samples 
being taken over th is  i n i t i a l  period  Values f o r  one horse a re  a lso  
a v a ila b le  and show a  very s im ila r  p a t te rn  (F ig . 3 ) .  The q u a n ti ty  o f  





H o u r s
F ig . 2. Cumulative uiAnaiy ex c re tio n  o f o r a l ly  ad m in istered  
p h en o th iaz in e .
E^ch graph l in e  re p re se n ts  one an im al.
■  rfe.n (dose 423mg; 6m ^kg body wt) measured ra d io a c tiv e ly .
•  Sheep ( a-  dose 21 .9g; 420m^kg body wt: B- dose 4 2 .^g;
8l^mg/kg body wt) measured as  phenothiazone a f t e r  o x id a tio n ,
o Horse (C- dose 60.0g; llOmg/kg body w t: D- dose 3 0 .Og; 
33mg/kg body wt: E- dose 70.0g; 123mg/kg body wt) 
measured as  phenothiazone a f t e r  o x id a tio n .
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F ig . 3» Blood le v e ls  o f  phenoth iazine and m etab o lite s  ( t o t a l ) 
a f t e r  o ra l a d m in is tra tio n .
Each graph l in e  re p re sen ts  one anim al.
•  Sheep ( a -  dose 47.0g; Qjymg/kg hody w t: B- dose 4 2 .5g; 
8l5mg/kg hody wt: C- dose 21 .9g; 420mg/kg hody wt: D- 
dose 38 . Og; wt no t s p e c if ie d  -  la c ta t in g  ewe: B- dose 
3 8 . 0g; wt not s p e c if ie d  — la c ta t in g  ewe).
o Horse (dose fO.Og; 123mg/kg hody wt ) .
A ll measured as phenothiazone a f t e r  o x id a tio n . 
Drawn from re c a lc u la te d  d a ta  (R efs, 76, 79) .
a sm all p ro p o rtio n  o f the  adm in istered  dose; a t  peak values th e  amount 
o f drug in  th e  to ta l  blood volume, assuming equal d is t r ib u t io n ,  only 
accounts f o r  about 1 to  Z% o f the  t o t a l  body burden.
A d e ta i le d  in v e s tig a tio n  in to  ra d io a c tiv e  blood le v e ls  has been 
c a r r ie d  out in  the  guinea p ig  fo llow ing o ra l in g e s tio n  o f (^ ^C )-lab e lled  
phenoth iazine . A sem ilogarithm ic p lo t  o f  the  d a ta  gives a  curve 
(F ig , 4) which i s  in d ic a tiv e  o f a  three-com partm ent model (ab so rp tio n , 
d is t r ib u t io n ,  e lim in a tio n ) . Only a few observations f e l l  in to  th e  
delayed p o r tio n  o f th e  curve where ab so rp tio n  became n e g l ig ib le ; 
n e v e rth e le ss , the  b io lo g ic a l h a l f - l i f e  can be estim ated  as  about 24
79hours. Id e n tic a l  trea tm en t o f the  scan ty  d a ta  a v a ila b le  f o r  th e  sheep 
g ives a  s im ila r  curve and an approxim ate h a l f - l i f e  o f  15 to  18 hours. 
Q u a n tita tiv e  s tu d ie s  o f  s e c re tio n  by way o f  th e  le s s  im portan t 
ro u te s  o f e lim in a tio n  a re  u n fo rtu n a te ly  even more l im ite d . B ilia ry  
se c re tio n  le v e ls  in  the  cow and guinea p ig  o f t o t a l  phenoth iazine  
and phenothiazone and o f  r a d io a c t iv i ty  re sp e c tiv e ly  show s im ila r  
p a tte rn s  (F ig , 5)» An i n i t i a l  peak occurs around 10 to  12 hours a f t e r
dosing in  the  cow and a t  13 to  l4  hours in  the  guinea p ig  to  be
follow ed by a  second la r g e r  peak 2 to  3 hours l a t e r  in  both  sp e c ie s .
No drug was d e tec ted  in  samples o f b i l e  c o lle c te d  from cows a t  120
8 lhours a f t e r  dosing
Several s tu d ie s  have shown th a t  coloured phenoth iazine d e r iv a tiv e s  
a re  sec re ted  in  the milk from cows, goats  and sheep, bu t only  one study 
w ith  sheep provides s u f f ic ie n t  s e r i a l  c o lle c tio n  d a ta  to  c o n s tru c t a  
cum ulative se c re tio n  curve (F ig , 6 ) , This curve has a  s im ila r  shape to  
th a t  fo r  u rin e  w ith  a  maximum se c re tio n  r a te  o ccu rrin g  in  th e  12 to  24 
hour p e rio d . However, although th e  amount o f drug sec re ted  i s  s u f f ic ie n t  
to  co lou r th e  e n t ire  milk y ie ld  i t  can be shown here to  account fo r









F ig . 4 . Sem ilogarithm ic p lo t  o f  blood r a d io a c t iv i ty  le v e ls  in  
th e  guinea p ig  a f t e r  o ra l  a d m in is tra tio n .
Each p o in t re p re se n ts  th e  mean o f  fo u r  anim als 
(dose 150m ^kg hody wt ) .
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Fig» 5« B i l ia iy  s e c re tio n  o f  o r a l ly  adm in istered  p h eno th iaz ine .
TOP. Cow -  h i l e  samples c o lle c te d  du rin g  p o s t mortem o f  18 
d a ily  cows a t  vary ing  tim es a f t e r  dosing . % >ecific doses no t 
given hu t range from 420mg to  l ,k 7 g /k g  hody w t. Drug was 
measured sp ec tro p h o to m etrica lly  a f t e r  hrom ination and a f t e r  
a c id  h y d ro ly s is . Dcawn from re c a lc u la te d  da ta  (R ef. 81 ).
BOTTOM. Guinea p ig  -  h i l e  samples c o l le c te d  con tinuously  v ia  
an indw elling  cannula. Dose l_$Omg/kg hody w t, 3uCi. Drug was 
measured ra d io a c tiv e ly . Each value re p re se n ts  th e  mean o f fo u r  











F ig , 6 . Cumulative s e c re tio n  o f o r a l ly  ad m in istered  phenoth iazine
in  sheep m ilk.
Graph rep resen ts va lu es from one animal (dose 3 8 . Og; hody 
wt not s p e c if ie d ) .
Measured as phenothiazone a f t e r  o x id a tio n .
Drawn from reca lcu la ted  data (R ef, 79)*
3. ADVERSE REACTIONS
A. INTRODUCTION
An in s ig h t in to  the mechanism o f in te ra c t io n  o f a  drug 
w ith  the  "biochemical system s w ith in  a  l iv in g  organism may be gained 
by a d e ta i le d  exam ination o f i t s  e f f e c ts ,  both  b e n e f ic ia l  and 
d e le te r io u s , fo r  any p e rc e p tib le  e f f e c t  which occurs must have an 
underly ing  p h y sio lo g ica l dysfunction  r e s u l t in g  from the d istu rbance  
o r modulation o f a  b io lo g ic a l even t. The work undertaken in to  the 
mode o f a c tio n  o f phenoth iazine on in te s t in a l  p a ra s ite s  i s  d iscussed  
in  d e ta i l  l a t e r .  The second avenue o f approach, d e a lt  w ith  below, i s  
through th e  exam ination o f the  v ario u s  s id e  e f f e c ts ,  the  unwanted 
re a c tio n s , which the  drug produces in  various an im als. However, 
before t h i s  avenue can be f r u i t f u l l y  explored i t  i s  necessary  to  
e s ta b lis h  what s p e c if ic  adverse re a c tio n s  take  p lace  a f t e r  
phenoth iazine ad m in is tra tio n .
U nfortunately , th e  e f fe c ts  o f  th e  drug a re  q u ite  v a r ia b le  ; 
not only between th e  sev e ra l sp ec ies  t r e a te d  bu t sometimes between 
in d iv id u a ls  belonging to  th e  same sp e c ie s . Animals have d ied  a f t e r  
rece iv in g  the  customary th e ra p e u tic  dose, whereas o th e rs  have 
surv ived  many tim es t h i s  amount. The various sp ec ie s  have been 
placed in  o rd er o f in c re a s in g  s e n s i t iv i ty  to  pheno th iazine  to x ic i ty  
(dogs, b ird s ,  r a b b i ts , g o a ts , sheep, c a t t l e ,  p ig s , ho rse, man) and 
i t  has been recommended th a t  sm all gradual doses o f  th e  drug be
126given r a th e r  than  la r g e r  doses , although continuous trea tm en t
may be more insiduous in  i t s  harmful e f fe c ts  and i t  i s  alm ost
c e r ta in  th a t  phenoth iazine would be to x ic  to  a l l  anim als i f  the
127 128acu te  o r  chronic dosage i s  too high ,
Undoubtably a v a r ie ty  o f fa c to rs  p lay a ro le  in  determ ining 
the s u s c e p t ib i l i ty  o f any animal a lthough id io syncrasy  a lone does 
not appear to  be a  s a t is f a c to ry  exp lanation  f o r  a l l  cases o f 
poisoning. Toxic m an ifesta tio n s  o f te n  tend to  occur in  groups, 
suggesting  some lo c a l is e d  environm ental o r  g en e tic  in flu en c e . One 
such example uncovered w h ils t in v e s tig a tin g  th e  an th e lm in tic  e f f ic ie n c y  
o f phenoth iazine found th a t  ju s t  under one q u a r te r  o f  th e  89 p a t ie n ts  
tre a te d  showed some form o f adverse re a c tio n  and th a t  th ree  who
129developed anaemia were s i s t e r s  , Another re p o r t  s ta te s  th a t  the
s i s t e r  o f  a  young g i r l  adm itted  to  h o sp ita l w ith  acu te  haem olytic
anaemia a f t e r  phenoth iazine trea tm en t had a lso  su ffe red  a  very s im ila r
130bu t m ilder a t ta c k  . One th in g  th a t  i s  apparen t i s  th a t  the  young 
o f a  sp ec ie s  a re  g e n e ra lly  more prone to  adverse re a c tio n s  than  
a d u l ts .
B. EFFECTS ON THE BLOOD ELEMENTS
The most w idely rep o rted  s id e  e f f e c t  o f phenoth iazine 
therapy i s  acu te  haem olytic anaemia and i t s  seq u elae . The s e v e r i ty  
o f th is  co n d itio n  can vary between being s l ig h t  and t r a n s ie n t  to  
f a t a l  in  i t s  outcome and has been rep o rted  as occu rring  in  many 
species  in c lu d in g  the mouse r a t  r a b b i t  dog
135, p ig  136,137, c a t t l e  h ,r se  76 ,135 ,139-147 , *^1 man 42 ,1 1 0 ,1 1 1 , 
130,148 166  ^ Anaemia has a lso  been dem onstrated ' in  chickens a f t e r  
phenoth iazine a d m in is tra tio n  bu t th i s  may have been due to  th e  ca tch in g  
and co n fin in g  o f the  b ird s  167 , 168^
I t  i s  d i f f i c u l t  to  o b ta in  a  r e l ia b le  measure o f the incidence o f  
haem olytic anaemia w ith in  a sp ec ie s  o r popu la tion  as  very many a r t i c l e s  
only c i t e  those  in d iv id u a ls  experiencing  s id e  e f fe c ts  and do not 
con ta in  c o n tro lle d  s tu d ie s .  N evertheless, th e  l i t e r a t u r e  c o n ta in s  
se v e ra l in s tan ce s  where horses have been e f f i c i e n t ly  dosed w ithout
the appearance o f  any c le a r  s ig n s  o f  in to x ic a tio n  49,169 173 i t  i s  
cer ta in  th a t many thousands o f  horses throughout the world have been 
s u c c e s s fu lly  trea ted  w ithout adverse rea c tio n , A few rep orts e x is t  
where the e f f ic ie n c y  o f  phenothiazine therapy in  humans has been stu d ied  
and the number o f  su b jects  developing any changes w ith in  th e ir  blood  
p r o f i le  have been c ite d  (Table 9 ) .  The observed o v era ll in cid en ce o f  
18^ i s  s im ila r  to  the 13^ quoted by Johnstone and Grant ^30,153 
th e ir  review o f  58 p a t ie n ts , although the la t e r  included nine p a tien ts
47treated  by one in v e s t ig a to r  who reported no s id e  e f f e c t s  . However, a 
wide v a r ia tio n  i s  seen  to  e x is t  between the various s tu d ie s  (Table 9 ) 
and the quoted mean value may be an underestim ate. M iller  and A llen  
have s ta te d  th at a s l ig h t  but d e f in ite  anaemia occurred in  about h a lf
o f  a group o f  73 ch ild ren , aged between 4  and 12 y ea rs , tr ea ted  w ith
phenothiazine and oth er workers have a lso  mentioned a  tra n s ien t
but measurable anaemia in  about h a lf  o f  th e ir  su b jects  ^-52,155^
N evertheless, severe  haem olytic anaemia has been c i te d  ^49,153
t h is ,  coupled w ith  th e report o f  a death due to  phenothiazine  
174 174poison in g  ' r e su lte d  in  th e general f e e l in g  th at i t s  use in  man 
was u n ju s t if ie d .
In  a d d itio n  to  th e  g en era l p ic tu re  o f a  decreased haemoglobin
con ten t, decreased red blood c e l l  count and an in crea se  in  the
132 134 42percentage o f  c ir c u la tin g  r e t ic u lo c y te s  (r a t  , dog ^ , man ) ,
an iso c y to s is  (co n sid erab le  v a r ia t io n  in  s ize )(d o g  horse ^47^ and
147p o ik ilo c y to s is  ( ir r e g u la r  shape)(horse ) have been observed as  w e ll 
as a polycythaem ia ( in crea se  in  number o f  red blood c e l l s  above normal),
177the la t e r  occurring in  lambs given frequent doses o f  phenothiazine  
E ffe c ts  on w hite blood elem ents in clu d e n eu tro p h ilia  (dog ^^4,176^^ low 
polymorphonuclear c e l l  counts (man ^49^ and a general p r e d isp o s itio n  to  
a gran u locytosis  (sheep man ^ ^ ) ,  Other s ig n s  reported in clu d e
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an in c re a se  in  l a c t i c  ac id  and b i l i r u b in  in  the  blood stream  (horse 
jaundice (dog ^^4, ^an n e p h r i t is  and h e p a t i t i s  (man ^49,166)^
Post mortem exam ination has shown severe in ju ry  to  th e  u rin a ry  system 
(horse to g e th e r  w ith  p a th o lo g ica l le s io n s  in  th e  kidney (sheep
18lin c lu d in g  changes in  the  tu b u les  and M alphigian co rp u sc les  (horse )
and coagulated  masses in  the  b lad d er, kidney h ilu s  and u re te rs  (ho rse  ) .
A mention o f organ congestion , f a t ty  degeneration  and advance cloudy
sw ellings o f  th e  l i v e r ,  i n t e r s t i t i a l  le s io n s  o f  th e  h e a r t  (horse
1Ô2 100and enlargem ent o f th e  sp leen  (horse  , weasel ) h e a r t ,  l i v e r  and 
kidneys (horse ^44^ has a lso  been made. Most, i f  no t a l l ,  o f th ese  
changes may w ell be secondary to  th e  haem olytic anaemia p re se n t.
C. NEUROMUSCULAR PBOBLEMS
Loss o f equ ipo ise  and power o f co o rd in a tio n  in  movement 
w ith  d i f f i c u l ty  in  w alking, s tag g e rin g  g a i t ,  muscle weakness and 
g en era l p a ra ly s is  o f  the  h ind  q u a r te rs  have been observed w ith  p ig s  
136,184-187^ horses 144,188,189 c a t t l e  xmdergoing phenoth iazine
tre a tm e n t. The phenomenon i s  th e  most dram atic in  p ig s  where some 
anim als a re  so bad ly  a f fe c te d  th a t  they a re  unable to  move, ly in g  
p ro s t r a te  w ith  op istho tonus (a  te ta n ic  spasm in  which th e  sp ine  and 
e x tre m itie s  a re  b en t w ith  convexity  forw ards) being observed in  a  few 
anim als The co n d itio n  can be f a t a l
D. PHOTOSENSITIZATION
Ihe phenomenon o f p h o to se n s it iz a tio n  has been f re q u e n tly  
described  in  man. The re a c t io n  c o n s is ts  mainly o f  an itc h y  ra sh  and 
inflam m atory d e rm a titis  resem bling sunburn, developing a f t e r  s e v e ra l 
hours d i r e c t  exposure o f the  sk in  to  su n lig h t.  The re p o rte d  cases 
have e i th e r  followed the  d ir e c t  co n tac t o f  th e  sk in  w ith  a  spray 
con ta in ing  phenoth iazine o r a d u s t o f  th e  chem ical ^^^“^^4 a f t e r
the  in g e s tio n  o f phenoth iazine (o r  in  one case th io n o l)  195, 
suggesting  th a t  both  a  to p ic a l i r r i t a t i o n  and a sytem ic mechanism may 
be in  o p era tio n . N evertheless, i t  i s  g en e ra lly  ap p rec ia ted  th a t  both 
the drug and d i r e c t  su n lig h t must be p re sen t fo r  the re a c tio n  to  occur; 
ranchers in  Texas avoid  th is  i r r i t a t i o n  by dosing t h e i r  herds a t  
n igh t
Other animal sp ec ies  a lso  show p h o to se n s itiz a tio n  b u t do no t r e a c t  
w ith  th e  same frequency. White an im als, o r  anim als w ith  w hite sp o ts , 
may re a c t  whenever unpigmented p a r ts  a re  exposed to  th e  sun. Animals 
having a  general pigm entation may only show an inflam m ation o f the  
cornea and a sso c ia ted  signs such as  la c rim a tio n  and oedema o f the  
e y e lid s . The k e r a t i t i s  may develop in to  o p ac ity  o f th e  cornea and 
eventual u lc e ra tio n  lead in g  to  temporary o r in  some cases permanent 
b lin d n ess . Such re a c tio n s , in  vary ing  degrees, have been rep o rted  as 
occurring  in  pigs ^^7, sheep 198- 201  ^ c a t t l e  59,202-205^ goats and
pheasants
E. OTHER REACTIONS
A v a r ie ty  o f o th e r  adverse re a c tio n s  have been c i te d  in
th e  l i t e r a t u r e  and have been lin k ed  w ith  phenoth iazine therapy . These
include shock resem bling anaphylaxis a f t e r  th e  o ra l  a d m in is tra tio n  to
a horse in c reased  t h i r s t  in  p igs and horses e n t e r i t i s
diagnosed a t  post mortem in  a horse and g a s tr o in te s t in a l  i r r i t a t i o n  
156in  man . Colicky p a in s , d ia rrh o ea  and c o n s tip a tio n  have a lso  been
1 Op
rep o rted  to g e th e r w ith  im paction o f th e  colon in  the  horse
Subnormal tem peratures have been recorded in  c a t t l e  and p igs 
155and fe v e r  in  man to g e th e r  w ith  a  s c a r l e t  ra sh  and s l i g h t  oedema 
about th e  eyes and hands ^-55,156^ Sores and severe  d e rm a tit is  resem bling
scab ies  have been described  in  p ig s 185,210 acu te  d e rm a titis  w ith
2H  ?e x fo lia tio n  has been rep o rted  in  man , Abortion in  sheep and an
213 214in c reased  incidence of s t i l l b o r n  lambs has a lso  been c ite d
4. MODE OF ACTION
Before th e  s p e c if ic  a sp ec ts  o f the mode o f  a c tio n  o f 
phenoth iazine and the  p o ss ib le  mechanisms by which th e  m ajor adverse 
re a c tio n s , now e s ta b lish e d  as  haem olytic anaemia, neuromuscular 
in co o rd in a tio n  and p h o to se n s itiz a tio n  can be examined in  d e ta i l  
i t  i s  im portan t to  r e a l i s e  th a t  s e v e ra l fa c to rs  o th e r than  the  
d i r e c t  biochem ical e f f e c ts  o f phenoth iazine o r i t s  m etabo lites  
may in flu en ce  the  o v e ra ll p ic tu re  o f  therapy and to x ic i ty  in  a 
given anim al. These w il l  be considered  f i r s t  be fo re  pursu ing  
exp lanations which evoke biochem ical in te ra c t io n s ,
A. CONTRIBUTING FACTORS
l ) , Im p u r itie s .
I t  i s  p o ssib le  th a t  poisoning r e s u lt in g  from th e  ad m in is tra tio n  
o f phenoth iazine i s  due to  im p u ritie s  w ith in  th e  p re p a ra tio n s . In 
e a s te rn  S ib e r ia  during  March 1955, 1350 fo a ls  were each given 40 to  
60 grams o f phenoth iazine as a  p ro p h y lac tic  measure. T h irty  o f the  
anim als became i l l  w ith in  two o r th re e  days a f t e r  dosing and 22 (1 . 6^) 
subsequently  d ied . On p o s t mortem exam ination an a lk a lo id  was d e tec ted  
in  the organs and a  compound, when recovered from th e  stomach con ten ts  
o f  th e  fo a ls ,  was shown to  be poisonous to  r a b b i ts .  I t  was proposed 
th a t  th i s  was derived from th e  phenoth iazine and was re sp o n s ib le  fo r  
the  poisoning  but i t  was not s ta te d  whether o r  not the a lk a lo id (s )  
was d e te c ta b le  in  the  phenoth iazine before a d m in is tra tio n  215 , 216^
The p o s s ib i l i ty  th a t  th e  f a t a l  compound was a p la n t  a lk a lo id  taken in  
w h ils t  feed ing  must a lso  be considered . In  an o th e r study invo lv ing
horses undergoing phenoth iazine trea tm en t i t  was concluded th a t  the
upset in  th e  blood p ic tu re  was caused to  a la rg e  e x te n t by im p u r it ie s ,
217mainly diphenylamine . Diphenylamine i s  employed in  th e  sy n th esis  
o f phenoth iazine and i s  i t s e l f  used to p ic a l ly  in  th e  treatm en t o f 
screwworm in fe s ta t io n s .  Large o ra l doses o f diphenylamine (up to  30 g) 
given to  sheep have been shown to  produce s im ila r  bu t more severe
218le s io n s  than  those o ccas io n a lly  found w ith  phenoth iazine
Several workers have shown th a t  commercial phenoth iazine reduces
the  uptake o f ra d io a c tiv e  iod ine  by the  th y ro id  gland 219-223 d id
224no t induce hypothyroidism  . Blood le v e ls  o f  io d in e  in creased  in
225sheep given phenoth iazine ^ and th e  th y ro id  glands o f t r e a te d  anim als
were shown to  co n ta in  n ea rly  tw ice a s  much io d in e  as  the  g lands from
co n tro l an im als, a lthough th e re  was no s ig n if ic a n t  in c rease  in  th e  mean
wet w eight . Such e f fe c ts  were no t seen when p u r if ie d  phenoth iazine
was adm in istered  and i t  i s  assumed th a t  they  were due to  io d in e  o r
221 223 227iod ide p re se n t a s  an im purity  in  commercial phenoth iazine * ;
iod ine  being used as a c a ta ly s t  in  i t s  s y n th e s is . O ther workers have 
suggested th a t  ano ther f a c to r ,  much le s s  p o ten t than  io d in e , was a lso  
re sp o n sib le  f o r  a s l ig h t  depression  o f th y ro id  uptake o f  ra d io a c tiv e
ppQ
io d in e , bu t i t s  id e n t i ty  has not been s ta te d
O ther compounds, such as  methylamine, can be added in  sm all amounts 
( 0.3  to  1 , 05^  w/w) to  phenoth iazine to  p reven t i t s  o x id a tio n  in  b r ig h t 
s u n lig h t, e sp e c ia lly  when in  th e  presence o f  a f in e ly  d iv id ed  in e r t  
c a r r ie r ,  which lead s  to  the  compound aq u ir in g  a  greenish-brow n t i n t .
I t  i s  p o ss ib le  th a t  th e se  tra c e  contam inants, e i th e r  rem aining from th e  
m anufacturing process o r  being d e l ib e ra te ly  added a f te rw a rd s , may add 
to  the to x ic  re a c tio n s  observed, e s p e c ia lly  as such la rg e  doses o f 
phenoth iazine a re  ro u tin e ly  g iven . However, s tu d ie s  employing p u r if ie d  
phenoth iazine have shown th a t  adverse re a c tio n s  s t i l l  occur.
2 ) . Physical e f f e c ts .
The p o st mortem fin d in g  o f  an impacted colon in  th e  horse to g e th e r 
w ith  many re p o rts  o f  c o n s tip a tio n  a f t e r  phenoth iazine trea tm en t suggest 
th a t  a la rg e  p ro p o rtio n  o f th e  dose, which may be up to  1 kg in  some 
horses i s  rem aining w ith in  the  low er gut lumen b rin g in g  about
bowel dysfunction  and lead in g  to  co lick y  pa ins and o th e r  d if fu s e  symptoms 
o f  genera l i l l  h e a lth  rep o rted  in  th e  l i t e r a t u r e  ^44,147,182,190^ i s  
a lso  p o ssib le  th a t  a  la rg e  amount o f  v i r tu a l ly  in so lu b le  phenoth iazine 
w ith in  the  colon w il l  in te r f e r e  w ith  w a te r reab so rp tio n  (d ia rrh o ea  has 
a lso  been rep o rted ) lead in g  to  an in c reased  t h i r s t  as  observed in  p igs 
and horses 76,184^ dehydration  rep o rted  in  ponies and im pairing  
the u rin a ry  ex c re tio n  o f th e  drug and i t s  m e tab o lite s , perhaps 
encouraging th e  form ation o f  in so lu b le  p r e c ip i ta te s  w ith in  th e  kidney. 
When lambs were su b jec ted  to  a  process o f  slow dehydration  they  were 
f a r  more s u sc e p tib le  to  phenoth iazine to x ic i ty  (k idney le s io n s )  than  
those  not dehydrated and th i s  i s  s tro n g ly  suspected a s  being a  f a c to r
0 * 1  O  p ' i l
p re c ip i ta t in g  m o rta lity  in  New Zealand sheep * . Phenoth iazine
i t s e l f  has been shown to  possess a  m ild d iu re t ic  a c tio n  and would
21 fith e re fo re  accen tu a te  the  s ta t e  o f dehydration
3 ) . N u tr itio n a l f a c to r s .
Animals su ffe r in g  from in fe c tio n  w i l l  be in  a  s ta t e  o f  g en era l
i l l  h e a lth  before phenoth iazine a d m in is tra tio n  and d ie ta ry  d e f ic ie n c ie s ,
w hether owing to  inadequate feed ing  in  i l l  h e a lth  o r  to  in s u f f ic ie n t
nu trim ent value o f  fodder, e s p e c ia lly  over the  w in te r  months, may g ive
l4 4  232r is e  to  a  general p re d ip o s itio n  to  to x ic i ty  * . Experience w ith  the
mass trea tm en t o f horses in  the  USSR in d ic a te d  th a t  to x ic  re a c tio n s  only
occurred  in  s ta b le d  horses during  the  w in te r  months and were thus
233a t t r ib u te d  to  n u tr i t io n a l  d e f ic ie n c ie s  . However, t h i s  p o in t i s  
c o n tro v e rs ia l w ith  some workers re p o rtin g  th a t  horses in  good o r f a i r
co n d itio n  a re  more l ik e ly  to  show severe anaemic re a c tio n s  than horses
in  th in  co n d itio n  whereas o th e rs  suggest th a t  em aciated o r aged
su b je c ts  a re  more a t  r i s k  and th a t  a  high p ro te in  d ie t  can p ro te c t, a t
145le a s t  in  p a r t ,  a g a in s t the  haem olytic e f fe c ts  o f phenoth iazine
Indeed, one dog on a d ie t  d e f ic ie n t  in  v itam in  B experienced a  g re a tly
in te n s i f ie d  anaemia and jaundice than th a t  norm ally induced by
phenoth iazine treatm ent a lthough  the  a d d itio n  o f v itam in  B complex to
134normal d ie ts  d id  not p reven t the  anaemia . In  chickens phenoth iazine 
has been shown to  in crease  th e  d ep o s itio n  o f v itam in  A in  th e  l iv e r s  
as  w ell as in c rease  th e  growth r a te  when added to  v itam in  E d e f ic ie n t  
d ie ts  con ta in in g  10^ cod l i v e r  o i l  The s ig n if ic a n c e  o f  th e se  l a t e r
observa tions and complex in te ra c t io n s  a re  no t known.
B. MECHANISM OF ANTHELMINTIC ACTION
*A com pletely s a t is f a c to ry  exp lanation  o f the  mechanism 
by which phenoth iazine e lim in a tes  nematodes has d e fie d  re sea rch  
workers f o r  over twenty years* .
That sta tem ent was d e liv e red  in  I 962 a f t e r  phenoth iazine had 
enjoyed two decades as the  most e f f i c i e n t  and w idely used an th e lm in tic  
on e a r th . With the d ec lin e  o f i t s  p o p u la r ity  s h o r t ly  a fte rw ard s  l i t t l e  
a d d itio n a l inform ation  has been gleaned and th e  p o s itio n  o f  understanding  
today shows l i t t l e  advance over th a t  achieved in  th e  *60*s .
Three fe a tu re s  o f  the a c tio n  o f  phenoth iazine which a re  d i f f i c u l t  
to  exp la in  a re  the requirem ent o f a r e la t iv e ly  la rg e  dose f o r  f u l l  
a c t iv i ty ,  th e  g re a te r  e f f ic ie n c y  a g a in s t  p a ra s i te s  o f the abomasum 
(fo u r th  d iv is io n  o f th e  ruminant stomach) caecum and colon compared 
w ith  those  o f  the sm all in te s t in e  and th e  mechanism by which th e  
p a ra s ite s  a re  removed.
I n v e s t ig a t io n s  w ith  p h e n o th ia z in e  and i t s  d e r iv a t iv e s  s u g g e s t
t h a t  th e  compound i s  n o t c o n v e r te d  in t o  an a c t i v e  a n th e lm in t ic  by 
102m etabolism  and i t  i s  th e r e fo r e  assum ed t h a t  th e  la r g e  d o se s  a re
r e q u ir e d  t o  en su re  th a t  th e  p a r a s it e  ab so rb s t o x i c  amounts o f  th e
unchanged d ru g . A lthough th e  compound has a  v e r y  low aqueous s o l u b i l i t y
(1.25  p .p .m .)  i t  i s  g e n e ra lly  accepted  th a t  i t  e n te rs  the  p a r a s i t ic
104nematode th rou gh  th e  c u t i c l e  and th u s  must be i n  s o lu t io n  b e fo r e
a b s o r p t io n  can  o c c u r . The r a t e  o f  s o lu t i o n  w i l l  depend upon th e  t o t a l
a v a i la b le  s u r fa c e  a r e a  o f  th e  drug and i f  t h i s  f a l l s  below  a  c r i t i c a l
l e v e l  th e  c o n c e n tr a t io n  o f  p h e n o th ia z in e  i n  s o lu t i o n ,  w hich  i s
c o n s ta n t ly  b e in g  removed by a b s o r p t io n  in to  th e  h o s t ,  w i l l  be to o  low
to  remove th e  p a r a s i t i c  nem atodes ev en  though s o l i d  p h e n o th ia z in e  may
s t i l l  be w i t h in  th e  g u t  lum en. T h is h y p o th e s is  i s  su p p orted  by
observations showing th a t  th e  an th e lm in tic  e f f ic ie n c y  in c reases  as
237-239th e  p a r t i c l e  s i z e  o f  th e  a d m in is te r e d  p h e n o th ia z in e  d e c r e a s e s  ^ ,
As a  c o r o l la r y  i t  seem s r e a so n a b le  t h a t  th e  a n th e lm in t ic  
e f f i c i e n c y  o f  p h e n o th ia z in e  in  th e  v a r io u s  p a r ts  o f  th e  g a s t r o i n t e s t i n a l  
t r a c t  i s  r e la t e d  to  th e  r e l a t i v e  d i f f e r e n c e s  i n  th e  drug c o n c e n tr a t io n  
and th e  tim e  f o r  w hich  th e y  p e r s i s t .  S in c e  th e  sm a ll  i n t e s t i n e  i s  th e  
s i t e  m ost h ig h ly  s p e c i a l i s e d  f o r  a b s o r p t io n  i t  i s  to  be e x p e c te d  t h a t  
i n  t h i s  r e g io n  th e  b a la n c e  betw een  a b s o r p t io n  by th e  h o s t  and s o lu t io n  
from th e  s o l i d  s t a t e  w i l l  be th e  m ost u n fa v o u ra b le  f o r  a n th e lm in t ic  
a c t io n
The t h ir d  p o in t  o f  i n t e r e s t  i s  th e  way i n  w h ich  p h e n o th ia z in e  
e l im in a te s  th e  p a r a s i t i c  nem atodes. As p r e v io u s ly  m en tion ed , t h i s  
ap p ears to  be a  p r o p e r ty  o f  p h e n o th ia z in e  i t s e l f  and n o t a  m e ta b o lit e  
No a n th e lm in t ic  a c t i v i t y  was n o t ic e d  when p h en o th ia zo n e  and t h io n o l  
w ere a d m in is te r e d  to  g o a t s  h e a v i ly  in f e c t e d  w ith  p a r a s i t i c  worms ^  
and th e  d o s in g  o f  p h en o th ia zo n e  to  sh eep  had no e f f e c t  on nem atodes  
p r e v io u s ly  shown to  be rem ovable by p h e n o th ia z in e  , A lso , m etabolism
of phenoth iazine w ith in  th e  nematode does no t seem to  occur; th e  
phenoth iazine con ten t o f nematodes taken  from tr e a te d  anim als d id  
not decrease when th e  worms were kep t in  a  d ru g -free  medium fo r  up 
to  24 hours, suggesting  th a t  once phenoth iazine has en tered  th e  p a ra s ite  
i t  has g re a t d i f f i c u l ty  in  leav in g
Phenothiazine does not e x e r t a  l e th a l  a c tio n  on th e  p a ra s i te  
as  worms e lim in a ted  from phenoth iazine tre a te d  anim als a re  a l iv e  and 
can be m aintained j j i  v i t r o  fo r  ju s t  as long as  p a ra s i te s  Arom u n trea ted  
anim als The only d e f in i te  e f f e c t  so f a r  dem onstrated bo th  vivo
and ^  v i t ro  i s  the  in h ib i t io n  o f  egg lay in g  which i s  thought not to  be 
r e la te d  to  any s p e c if ic  drug a c tio n  on th e  nematode rep ro d u ctiv e  
system b u t an o v e ra ll change in  th e  w ell being o f th e  a d u lt
M etabolic s tu d ie s  have shown th a t  phenoth iazine has th e  a b i l i t y  
to  form two redox systems (Scheme 3) &nd i t  has been p o s tu la te d  th a t  
such systems may preven t th e  o p era tio n  o f an oxygen t r a n s f e r  mechanism 
e s s e n t ia l  to  helm inth metabolism and th u s  be r e la te d  to  i t s  an th e lm in tic  
a c t iv i ty .  C ircum stan tia l evidence fo r  t h i s  view comes from s tru c tu re  /  
a c t iv i ty  s tu d ie s  which showed th a t  phenoth iazine d e r iv a tiv e s  w ith  
s u b s t i tu e n ts  in  both th e  3 -  and 7 -p o s itio n s , which precludes the  
form ation  o f such redox system s, a re  devoid o f an th e lm in tic  a c t iv i ty .  
Only a  few compounds w ith  s u b s ti tu e n ts  in  th e  3 -p o s it io n  d isp layed  
any a c t iv i ty  and an apparen t a s so c ia tio n  was found between th e  
an th e lm in tic  a c t iv i ty  o f  a compound and th e  a b i l i t y  to  form semiquinones 
w ith  o x id a tio n  p o te n tia ls  in  th e  reg io n  o f 550-850 mV ^4^. However, 
d e sp ite  much th e o re t ic a l  reason ing  th a t  such systems may p lay  a ro le  
in  th e  ac tio n  o f  pheno th iazine , th e  a c t io n  o f th e  drug o r  o f a 
m etabo lite  on any nematode redox system which could account fo r  th e  
an th e lm in tic  a c tio n  remains to  be dem onstrated.
p h e n o t h i a z o n e
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Scheme 3» Redox systems p re se n t in  phenoth iazine m etab o lites
and t h e i r  p o ss ib le  o x id a tiv e  in te ra c t io n  w ith  t i s s u e  
components.
c.  INHIBITION OF ENZYME ACTIVITY
Over th e  years from 1940 to  1955» the  tim e when phenoth iazine 
enjoyed immense p o p u la r ity , se v e ra l workers repo rted  th a t  the  compound 
and i t s  m etabo lites  d isp layed  in h ib ito ry  e f f e c ts  towards the  in  v i t r o  
a c t iv i ty  o f a wide v a r ie ty  o f  enzyme system s. This d a ta  has been 
c o lla te d  and co n ta in s  enzyme systems belonging to  th e  fu n c tio n a l 
c a te g o rie s  o f ox idoreductases, hydrolases and tra n s fe ra s e s  ( ih b le  1 0 ), 
S pecu lation  as to  th e  means o f  in h ib i t io n  has been made bu t th e re  
appears to  be no sim ple u n ify ing  c h a r a c te r is t ic  o r  p ro p erty  possessed  
by th ese  d iv e rse  enzyme systems to  make a  u n iv e rsa l in h ib ito ry  mechanism 
p o ss ib le  and i t  i s  probable th a t  sev e ra l modes o f  a c tio n  a re  involved ,
l ) ,  Sulphydryl. in tera ctio n .
In v e s tig a tio n s  have rev ea led  th a t  th e  a c t iv i ty  o f  r a t  l i v e r  
su cc in ic  dehydrogenase, an enzyme o f th e  t r ic a rb o x y lic  a c id  cycle 
which ca ta ly se s  th e  o x ida tion  o f  su cc in ic  a c id  to  fum aric ac id  (Bg., l ) ,  
i s  in h ib i te d  by quinones and r e la te d  compounds and i t  has been
249suggested  th a t  th e  sulphydryl .groups o f the  enzyme may be involved
COOK COOH
4 -^^2 + FAD-Enz  >  fp + FADH_-Enz
GIL HCI 2 I
COOH COOH
su cc in ic  a c id  fum aric a c id  (Eq, l )
A s im ila r  type o f mechanism was advocated fo r  the  in h ib i to ry  e f f e c ts  
o f  phenoth iazine d e r iv a tiv e s  th a t  have q u in o n e-lik e  s tru c tu r e s ,  eg, 
phenothiazone. I t  was fu r th e r  assumed th a t  th ese  d e r iv a tiv e s  would 
a c t  on the su lphydryl groups o f g lyoxylase (aldoketom utase), an enzyme 
system which c a ta ly se s  th e  in tram o lecu la r o x id a tio n -red u c tio n  o f 
m ethylglyoxal (pyruvic aldehyde) to  l a c ta t e  and employs g lu ta th io n e
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about in h ib i t io n  o f i t s  a c t iv i ty .  This was found to  be the case bu t 
in h ib i t io n  s t i l l  occurred  even in  th e  presence o f  a la rg e  excess o f 
g lu ta th io n e  which i s  known to  a c t  as a  p ro te c tiv e  agen t fo r  th ese  
sulphydryl groups. This was in  d i r e c t  c o n tra s t to  th e  observation  
made w ith  p-chlorom ercuribenzoate , which i s  known to  in h ib i t  enzymic 
a c t iv i ty  by re a c tin g  w ith  su lphydryl g roups, as  th i s  l a t t e r  compound
l o s t  i t s  in h ib i to ry  p ro p e r tie s  in  th e  presence o f  excess g lu ta th io n e
120 . Undoubtably some a d d it io n a l  ex p lan atio n  i s  re q u ired .
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2 ). Redox system s.
The ex isten ce  o f  two o x id a tio n -red u c tio n  systems amongst th e  
m etabo lites  o f phenoth iazine (phenothiazone /  leucophenothiazone ; 
th io n o l /  leu co th io n o l ; see Scheme 3) has prompted th e  suggestion  
th a t  the in h ib i t io n  o f  su cc in ic  dehydrogenase may be r e la te d  to  th e  
high redox p o te n tia ls  possessed by th ese  system s. Phenothiazone has 
an value o f +0.13 v o lts  a t  pH 7.3 and th e  th io n o l system an E  ^ o f  
0.16 v o lts  a t  pH 7.0» both o f which a re  h i ^ e r  than th a t  o f  the  
fum arate-succ inate  couple (E^ = 0.03 v. ,pH 7 .0 ) I t  i s
p o ssib le  th a t  in  g en era l such redox re a c tio n s  may be r e la te d  to  th e  
observed enzyme in h ib i t io n s .  However, th e  red u c tio n  p o te n t ia l  values 
were determ ined in  v i t r o  and apply  only to  ^0% reduced systems a t  th e  
given pH values and i t  i s  f a r  from c e r ta in  th a t  th ese  re p re se n t th e  
systems as  they a c tu a l ly  occur in  l iv in g  c e l l s .  The v a r ia t io n  o f pH 
in  v i t ro  i s  known to  markedly a f f e c t  the  red u c tio n  p o te n t ia l  o f  th e  
th io n o l system (Tfeible qq) 28»73^
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The in h ib ito ry  e f fe c ts  seen w ith  phenoth iazine may w ell be due
to  o x id a tio n  w ith in  th e  incubation  medium to  form phenothiazone /
leucophenothiazone. I t  has been shown th a t  phenoth iazine com pletely
in h ib i te d  th e  a c t iv i ty  o f cytochrome ox idase , the te rm in a l member o f
th e  cytochrome chain  capable o f reducing oxygen (% . 3)» in  cockroach
muscle bu t only a f t e r  one hour o f p re -in cu b a tio n  duidng which tim e
243only  p a r t i a l  in h ib i t io n  occurred The death  o f cockroaches owing
to  th e  in h ib i t io n  o f  cytochrome oxidase has a lso  been specu la ted  bu t 
no experim ental d e ta i l s  were given .
0 + Z l t  + ks~  ^  20H" (% . 3 )
I t  i s  known th a t  cytochrome oxidase i s  re a d ily  au to -o x id izab le  
only in  th e  presence o f  cytochrome c , probably forming a  ' cytochrome 
a (ox idase) -  cytochrome c complex* before  a c t iv i ty  can occur. 
Spectrophotom etric s tu d ie s  have shown th a t  leucophenothiazone can 
reduce cytochrome c bu t i t  was not c e r ta in  w hether o r  no t t h i s  re a c tio n  
was r e v e rs ib le .  I t  i s  p o ss ib le  th a t  the  in h ib i t io n  o f  cytochrome oxidase 
a c t iv i ty  occurs by th e  m aintainance o f  cytochrome c in  i t s  reduced 
s t a t e
3 ) .  O ther mechanisms.
The in h ib i t io n  o f c a ta la s e  a c t iv i ty ,  a  hydroperoxidase enzyme
which breaks down hydrogen peroxide w ith  th e  ev o lu tio n  o f  m olecular
oxygen (Bg. 4 ) ,  by the hydroxy-phenothiazines has been a t t r ib u te d  to
the  phenolic -OH group which p o ssib ly  forms covalen t complexes w ith
242th e  a c tiv e  iro n  atoms o f th ese  haemoprotein c a ta ly s ts
HgOg ------------- >  2H^0 + Og (01. 4)
I t  might he expected th a t  a  molecule o f phenothiazine*s s tru c tu re
would in te rc a la te  by van d e r Waals bonding to  o th e r arom atic r in g
systems thereby b inding  to  th e  porphyrin  /  c o rr in  ( ' t e t r a p y r r o le *)
r in g  s tru c tu re  o f haemoproteins o r  b ind ing  to  p ro te in  re s id u es  and
b rin g in g  about d is ru p tio n  o f t h e i r  t e r t i a r y  s tru c tu r e .  This could be
a  common mechanism by which phenoth iazine and i t s  d e r iv a tiv e s  a re  ab le
to  in h ib i t  th e  a c t iv i ty  o f such a  fu n c tio n a lly  d iv e rse  range o f enzyme
system s. Indeed, phenothiazone and th io n o l have been shown to  b ind  to
121serum albumin and nu c le ic  a c id s  and re c e n t n .m .r. s tu d ie s  have
suggested  th a t  s u b s t i tu te d  pheno th iazines can b rin g  about changes in
th e  p ro te in  co n fig u ra tio n s  in  red  blood c e l l  membranes (haem olytic
250anaemia ?) and so t h i s  remains a  r e a l  p o s s ib i l i ty  ,
Since the  mid I950*s no f u r th e r  work has been undertaken to  
e lu c id a te  th e  mechanism(s) o f  phenoth iazine-induced  enzyme in h ib i t io n  
and th e  suggestions c i te d  above a re  based on very  l i t t l e  i f  any 
evidence o th e r than  th e  observ a tio n  o f in h ib i t io n  w ith  a  given 
compound.
Some o f th ese  e f fe c ts  (Table 10) may be r e la te d  to  the  observed 
s id e -e f fe c ts  o f  th e  drug b u t extreme cau tio n  must be a p p lied  when 
a ttem p tin g  to  e x tra p o la te  d a ta  ob ta ined  from ^  v i t r o  experim ents 
to  th e  in  vivo s i tu a t io n .
D. PHENOTHIAZINE-INDUCED ADVERSE REACTIONS
l ) . Haemolytic anaemia.
As w ith  a l l  the to x ic  e f f e c ts  a sc r ib e d  e i th e r  d i r e c t ly  o r  
in d ir e c t ly  to  phenoth iazine therapy  th e re  i s  a  marked v a r ia t io n  in  
the  s u s c e p t ib i l i ty  o f d i f f e r e n t  sp ec ies  to  i t s  haem olytic m an ife s ta tio n s . 
W hilst man, horse and dog a re  most prone to  th is  adverse  re a c tio n , no
s i g n i f i c a n t  b lo o d  changes have been  r e p o r te d  in  th e  g u in e a  p ig  o r  
134g o ld e n  ham ster .
( i ) .  D ir e c t  a c t io n .
The o b s e r v a t io n  o f  an  in c r e a s e  i n  e r y th r o c y te  f r a g i l i t y
p r e c e e d in g  p h e n o th ia z in e - in d u c e d  anaem ia i n  dogs was in te r p r e te d
a s  b e in g  due to  th e  d i r e c t  a c t io n  o f  th e  compound and i t s  d e r iv a t iv e s
134on e r y th r o c y t e s ,  s u b se q u e n t ly  p rod u cin g  h a e m o ly s is  . E xperim ents
w ith  th e  p h e n o th ia z in e  d e r iv a t iv e s  prom azine and ch lorp rom azin e  have
d em on stra ted  .th a t ^  v i t r o  in c u b a t io n  w ith  human and dog e r y th r o c y te s
r e s u l t e d  i n  a  r a p id  h a e m o ly s is  and t h a t  th e  in tr a v e n o u s  a d m in is tr a t io n
o f  t h e s e  s u b s ta n c e s  in  th e  dog produced s im i la r  r e s u l t s .  T h is e f f e c t
was th o u g h t to  be due to  an in c r e a s e  i n  th e  p e r m e a b il ity  o f  th e  red
251c e l l  membranes to water or macromolecules . I t  has Eilso been shown
t h a t  s u b s t i t u t e d  p h e n o th ia z in e s  in d u ce  ap p aren t c o n fo r m a tio n a l ch an ges
250in  th e  p r o t e in  p h a se  o f  e r y th r o c y te  g h o s t s  and t h a t  ch lorp rom azin e
and i t s  a n a lo g u e s  a n ta g o n ise  c a lm o d u lin -s t im u la te d  + Ga^’^ )-ATP*ase
a c t i v i t y  ( p o s s ib ly  n e c e s s a r y  f o r  m ic r o tu b u le  i n t e g r i t y )  i n  s im i la r  
252p r e p a r a tio n s  . A lthough no su ch  d e t a i l e d  work h as been  u n d ertak en
w ith  p h e n o th ia z in e  i t s e l f  and i t  must be remembered t h a t  t h e s e
N - s u b s t itu te d  p h e n o th ia z in e s  p o s s e s s  c o m p le te ly  d i f f e r e n t  p h y s ic a l ,
ch e m ic a l and p h y s io lo g ic a l  p r o p e r t ie s  from  th e  p a r e n t  compound, i t  i s
q u i t e  p o s s ib le  t h a t  p h e n o th ia z in e  may i n t e r a c t  w ith  th e  l i p i d  p h a se  o f
th e  membrane ow ing t o  i t s  h ig h  l i p i d - s o l u b i l i t y  o r  b in d  to  th e  p r o t e in
p h ase  by van d e r  W aals in t e r a c t i o n ,  a s  has been  shown f o r  th e  o x id a t io n
121p r o d u c ts  p h en o th ia zo n e  and t h io n o l  , th e r e b y  b r in g in g  ab ou t ch an ges
in  m o le c u la r  o r ie n t a t io n  and membrane p e r m e a b il i ty .  In d eed , ex p er im en ts
p r e v io u s ly  r e p o r te d  i n  d e t a i l  have shown t h a t  p h e n o th ia z in e  and i t s
d e r iv a t iv e s  become bound t o  th e  membranes o f  e r y th r o c y te s  b u t do n o t  
e n te r  in t o  th e  c e l l s  5 5 ,6 3 ,8 0 ,1 1 9 -1 2 1 ^
However, s tu d ie s  invo lv ing  5qi v i t r o  incubations o f  human and 
horse e ry th ro cy tes  (two su sc e p tib le  sp e c ie s )  w ith  phenothiazine 
m etabo lites  f a i le d  to  rev e a l any haem olytic a c tio n  i t  i s
p o ss ib le  th a t  th e se  compounds may damage th e  e ry th ro cy te  in  such a  
way th a t  they  a re  then s e le c te d  fo r  removal by th e  r e tic u lo e n d o th e lia l  
system . I f  so , then  su b tle  changes in  th e  su rface  c h a r a c te r is t ic s  o r 
a l te r a t io n s  in  shape o r  p la s t i c  p ro p e r tie s  o f th e  c e l l  may be 
s u f f ic ie n t  to  i n i t i a t e  th i s  p ro ce ss . O verstim ulation  o f th e  sp leen  
and d e s tru c tio n  o f e ry th ro cy te s  by h y p e ra c tiv ity  has a lso  been 
proposed and d e sc rip tio n s  o f  splenomegaly lend  some support to
^ . 140,254such a hypothesis  .
( i i ) .  In d ire c t  a c tio n .
In  1942 i t  was rep o rted  th a t  the dii v i t r o  haem olysis o f  horse
e ry th ro cy te s  by saponin  and ly s o le c i th in  was ra p id ly  a c c e le ra te d  in
the  presence o f phenothiazone o r  the potassium  leucophenothiazone
su lphate  conjugate; e ry th ro cy tes  from sheep (a  more r e s i s t a n t  sp e c ie s )
req u ired  th ree  tim es th e  co n cen tra tio n  o f  th e se  chem icals to  produce
the  same r a te  o f haemolysis as  w ith  horse c e l l s .  A co n cen tra tio n  o f
3 X 10"^M o f th e  con jugate has been d e tec ted  in  horse plasma a f t e r
phenoth iazine trea tm en t which, 5qi v i t r o , was s u f f ic ie n t  to  cause a
253very marked a c c e le ra tio n  o f ly s o le c i th in  induced haem olysis . 
L y so lec ith in , which i s  a  normal component in  mammalian c i r c u la t io n  
p a r t ic u la r ly  the ho rse , and saponin  a re  su rfa c e  a c tiv e  agen ts  
( 'd e te r g e n ts ')  and powerful l y t i c  ag en ts . The mechanism by which th e  
phenoth iazine d e r iv a tiv e s  a c c e le ra te  th is  haem olytic p rocess i s  no t 
known bu t i t  i s  b e liev ed  th a t  th e  red  blood c e l l s  a re  being c o n s ta n tly  
su b jec ted  to  l y t i c  tendencies and the  presence o f such a  drug hastens 
th is  p ro cess  o f l y s i s ,  perhaps by an independent bu t a d d it iv e  e f f e c t  
on the c e l l  membrane (se e  above).
I t  i s  known th a t  most haem olytic drugs a re  a c tu a l ly  o r  p o te n tia l ly
arom atic compounds capable o f forming re v e rs ib le  o x id a tio n -red u c tio n
systems Phenothiazine i s  known to  be metabolised in  vivo to form
two such redox systems (se e  Scheme 3 ) ,  Such compounds have th e  p roperty
o f re a c tin g  w ith  oxygen probably to  form oxidan t in te rm ed ia tes  o r  f re e
ra d ic a ls  which a re  capable o f o x id is in g  haemoglobin and o th e r
in t r a c e l lu la r  components. Small amounts o f methaemoglobin have been
253
detec ted  when e ry th ro cy tes  were incubated  w ith  phenothiazone . The
p o s s ib i l i ty  o f  photodynamic haem olysis, such a s  seen  w ith  ro se  bengal
o r  eosin  where damage to  th e  c e l l  membrane i s  caused by energy t r a n s f e r
from a  ra d ia t io n  induced ex c ited  s t a t e  o f the absorbed drug molecule to
the  membrane has been d iscounted  s in ce  in  v i t r o  in cu b a tio n s  o f
horse e ry th ro cy tes  w ith  phenothiazone under i r r a d ia t io n  produced no
253d e te c ta b le  haemolysis
Free in t r a c e l lu la r  th io ls ,  o f  which g lu ta th io n e  i s  th e  major 
source , a re  a lso  ox id ised  o r  destroyed  and w ith  th e  d e p le tio n  o f  th e  
c e l l ' s  reducing cap ac ity  th e  continued in te g r i ty  o f th e  e ry th ro cy te
2^7-0
i s  sev e re ly  th rea ten ed  . The o x id a tio n  o r  b locking  o f  red  c e l l  
th io ls  i s  known to  be a s so c ia te d  w ith  in c reased  membrane p erm eab ility  
and haem olysis in  v i t ro  260,26l^ This in c reased  s u s c e p t ib i l i ty  o f  the  
c e l l  to  o x id a tiv e  s t r e s s  lead s  to  th e  spontaneous o r  a c c e le ra te d  
o x id a tio n  o f haemoglobin and i t s  subsequent lo s s  o f  normal c o n fig u ra tio n . 
The denatured  haemoglobin then  undergoes po lym erisa tion  and i s  d ep o sited  
as  sm all dense bodies beneath th e  red  c e l l  membrane. These in c lu s io n  
bodies (Heinz bodies) a re  p re sen t in  sm all numbers in  some normal 
e ry th ro cy tes  as they  approach th e  end o f  t h e i r  u se fu l l i f e  span (about 
120 days) and consequently th i s  'prem ature ag e in g ' induced in  th e  c e l l  
may be a s ig n a l f o r  t h e i r  s e le c t iv e  removal by th e  r e t ic u lo e n d o th e lia l  
system.
( i i i ) .  Genetic p re d isp o s itio n .
The appearance o f Heinz bodies i s  a fe a tu re  of phenothiazine
induced anaemia th a t  has been observed in  monkeys horses
dogs and mice The a d m in is tra tio n  o f th io n o l to  the  l a t t e r
131rodent a lso  produces th is  phenomenon . The f a c t  th a t  Heinz bodies 
can be dem onstrated in  th e  red  c e l l s  fo llow ing  exposure to  phenoth iazine 
in d ic a te s  th a t  the  c e l l s  a re  a c tu a lly  damaged. The degree o f damage 
v a r ie s  between in d iv id u a ls  and may be p a r t ly  a t t r ib u te d  to  an 
abnorm ality  o f  th e  e ry th ro cy tes  them selves.
Heinz bodies a re  u su a lly  p resen t in  in creased  numbers in  th e
c e l l s  o f  p a t ie n ts  w ith  haem olytic anaemia th a t  i s  caused by a
co n g en ita l s u s c e p t ib i l i ty  to  many drugs such as  phenylhydrazine, 
naphthalene, th e  a n t im a la r ia ls , sulphonamides and o th e r  a n t ib a c te r ia l  
agen ts . This s u s c e p t ib i l i ty  i s  due to  a r e la t iv e  d e fic ien cy  in  the  
a c t iv i ty  o f a s p e c if ic  enzyme, glucose-6-phosphate dehydrogenase (G6PD), 
the f i r s t  enzyme o f the  hexose monophosphate shunt which c a ta ly se s  the  
conversion o f g lucose-6-phosphate to  6-phosphoglucono-S-lactone w ith  
the p roduction  o f NADPH (Bq. 5)«
HgO^ POCHg HgO^ POCHg
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K  Sh H —  k  OH H / = °  + ™
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glucose-6-phosphate 6-phosphoglucono-S-lactone (Eq. 5)
A decrease in  the a c t iv i ty  o f th is  enzyme lead s  to  a  decrease in  the 
a v a i l a b i l i ty  o f NADPH and subsequent impairment o f  g lu ta th io n e  red u c tio n , 
re s u l t in g  under c e r ta in  cond itions in  o x id a tiv e  d én a tu ra tio n  o f 
haemoglobin and eventual ly s i s  o f  th e  red blood c e l l s .
This d e fic ien cy  i s  in h e r ite d  as an X -linked  re c e ss iv e  d iso rd e r  
th a t  has a  high frequency amongst Negroes. In  A frica  about 20^ o f males 
(hem izygotes) and about 4^ o f fem ales (homozygous fo r  th e  abnormal gene) 
a re  a f fe c te d . A sm all number o f heterozygous fem ales a re  a lso  d e f ic ie n t  
o f g6PD. a s im ila r  d e fic ien cy  occurs in  Caucasian and Mongoloid races 
where i t  i s  u su a lly  more sev ere . The d iso rd e r  i s  not a  c le a r  cu t presence 
o r absence o f a c t iv i ty  bu t e x is ts  as many phenotypes p o ssessing  d if f e r in g
262degrees o f d efic ien cy
In d iv id u a ls  w ith  g6PD d e fic ien cy  normally enjoy good h e a lth  bu t 
a re  l ia b le  to  haemolysis i f  any in crim in a ted  drug o r  food (eg . broad bean; 
V icia  faba -  Favism) i s  in g es ted . The haem olytic e f f e c t  i s  r e la te d  to  
the  dose and w il l  not be c l in ic a l ly  d e te c ta b le  i f  th e  amount does no t 
exceed a  c r i t i c a l  le v e l ,  which w i l l  vary w ith  d if f e r e n t  in d iv id u a ls  
depending upon the degree o f d e fic ien c y  and o th e r  p red isp o sin g  f a c to rs  
such as in fe c tio n . Some doses a re  then  non to x ic .  In  c e r ta in  types o f 
G6PD d e fic ien cy  th e  young e ry th ro cy te s  do have some G6PD a c t iv i ty  and 
remain v ia b le  u n t i l  th i s  a c t iv i ty  decays when they  become su sc e p tib le  
to  haemolysis
Such an enzyme d e fic ien cy , which has exp lained  th e  haem olytic 
anaemias caused in  c e r ta in  in d iv id u a ls  by se v e ra l o ffend ing  drugs, may 
go p a r t  o f  th e  way to  exp la in  th e  haem olytic e f fe c ts  o f  pheno th iazine .
The in h ib i t io n  of G6PD by various s u b s t i tu te d  pheno th iazines has been 
dem onstrated iqi v i tro  bu t phenoth iazine  and i t s  sulphoxide were no t 
examined owing to  t h e i r  low aqueous s o lu b i l i ty  . An in te r e s t in g  p o in t 
i s  th a t  th e  cases o f  severe haem olytic anaemia rep o rted  in  th e  medical 
p ress  appear to  occur in  young g i r l s  (6 to  10 years o ld ) ^50,153,17^,175^ 
a rev e rse  s i tu a t io n  to  th a t  expected from th e  knowledge o f  the X -linked  
mode o f in h e rita n c e  o f G6PD d e fic ien cy  where i t  would be assumed th a t  
more males would show the  d e fic ien cy  (eg . haem ophilia).
2 ) .  Neuromuscular problems.
Neuromusc u la r  in co o rd in a tio n  in  c a t t l e  has been shown to  he dose 
dependent; anim als rec e iv in g  36 to  52 g (c . 440 mg/kg body w t.)  o f 
phenoth iazine had no s id e  e f fe c ts  whereas those re ce iv in g  250 g 
developed ano rex ia  and in co o rd in a tio n  o f the  hind le g s  . Again, 
v a r ia b i l i ty  amongst th e  same sp ec ies  i s  observed a s  w ell as th a t  which 
e x is ts  between d i f f e r e n t  sp ec ie s . I t  has been s ta te d  th a t  o f  a  thousand 
p igs tre a te d  w ith  pheno th iazine , only one m ild re a c tio n  was encountered 
whereas, in  o th e r  herds the  m ajo rity  o f  anim als have re a c te d , some 
f a t a l ly  i t  i s  q u ite  p o ss ib le  th a t  some lo c a l  environm ental
f a c to r  i s  a t  p lay  o r  perhaps a  p red isposing  g e n e tic  s u s c e p t ib i l i ty ,  
exaggerated by herd inb reed ing .
A r ig id  te ta n ic  spasm w ith  in c reased  m uscular tone, such as 
observed in  p igs (op isth o to n u s) i s  u su a lly  a s so c ia te d  w ith  damage
o f th e  upper motor neurones as opposed to  the  lo c a l is e d  f la c c id  p a ra ly s is  
seen w ith  low er motor neurone le s io n s .  The s tag g e rin g  g a i t  w ith  lo ss  o f 
balance and power o f  co o rd in a tio n  ^36,144,184-190 su g g estiv e  o f 
c e re b e lla r  involvement and p o s s ib ily  extrapyram idal le s io n s .  Such 
problems a re  w ell known s id e  e f fe c ts  o f the  N -su b s titu te d  phenoth iazine . 
drugs such as chlorprom azine, p ro ch lo rperaz ine  and promazine which have 
been rep o rted  as causing inv o lu n ta ry  movement d iso rd e rs  and even se iz u re s  
in  some p a t ie n ts  I t  has been suggested  th a t  t h i s  e f f e c t  i s  due to
the  in te rfe re n c e  o f  dopaminergic tran sm iss io n  in  th e  b asa l g an g lia  
( ' extrapyram idal g a n g lia *) owing to  the  s p a t ia l  s im i la r i ty  o f th e
267phenoth iazines and dopamine (F ig . 7 ) and th i s  could  a lso  be th e  case 
f o r  phenothiazine i t s e l f  which i s  known to  be co ncen tra ted  in  th e  human 
b ra in
In a d d itio n  to  these  c e n tra l  a c tio n s , p e r ip h e ra l e f fe c ts  on the  
neurom uscular ju n c tio n s  o f s k e le ta l  muscle c e l ls  ( n ic o tin ic  re c e p to rs )  




F ig . 7. s t r u c tu r a l  s im i la r i ty  o f  phenoth iazine and dopamine.
M olecular models o f chlorprom azine (A) and dopamine (B ). 
(£ ) I l l u s t r a t e s  how dopamine may be superimposed on a  
p o r tio n  o f  th e  chlorprom azine molecule (Ref. 267) .
shown to  depress neuromuscular tran sm iss io n  and r a i s e  the  e x c ita tio n
th re sh o ld  p o te n tia l  in  th e  shore crab  ( Garcinus maenus) a t  very low
268co n cen tra tio n s  (c . 0 .5  uM) and th i s  may be th e  r e s u l t  o f  a  d i r e c t  
e f f e c t  on th e  neuronal membrane. I t  i s  known th a t  cu ra re , an a lk a lo id  
which produces a  non -depo laris ing  blockade a t  c h o lin e rg ic  (n ic o tin ic )  
te rm in a ls , has no e f fe c t  a t  th e  nerve-m uscle ju n c tio n  o f  the c rab  which 
a r e ,  th e re fo re , d i f f e r e n t  from th e  neurom uscular ju n c tio n s  found in
269mammalian system s where cu ra re  i s  a p o ten t b lock ing  agent
Phenothiazine i t s e l f  has no e f f e c t  in  v i t r o  on l i v e r  f lu k es
(F a sc io la  h ep a tica ) and f a i le d  to  evoke any response in  the  exposed
270—272neurom uscular apparatus o f the roundworm ( A scaris s p . ) , Both
the l i v e r  f lu k e  and roundworm m usculature a re  s tim u la ted  by a c e ty lc h o lin e  
and possess c h o lin e rg ic  components bu t i t  i s  not c e r ta in  th a t  th e
236a c e ty lc h o lin e -c h o lin e rg ic  system i s  im portan t in  nematode physiology /  
271 273* . However, 3^  v i t r o  s tu d ie s  w ith  phenothiazone, th e  ox ida tion
product o f  pheno th iazine , have shown i t  to  produce p a ra ly s in g  e f fe c ts
on both th e  la rg e  roundworm ( A scaris lu m brico ides) and th e  l i v e r  f lu k e ,
ra p id ly  being f a t a l  to  th e  l a t t e r .  Thionol and the  sulphoxide were l e s s
274 275e f fe c t iv e  bu t s t i l l  produced p a ra ly s is  in  both p a ra s i te s  .
In v e s tig a tio n s  in  th e  horse have a lso  shown phenothiazone to  be a  p o te n t
245 247in h ib i to r  o f serum c h o lin e s te ra se  and i f  th i s  in h ib i t io n  a lso
occurs w ith  the enzyme from nervous t i s s u e  i t  may serve  to  exp la in  th ese  
adverse re ac tio n s  because o f th e  ro le  o f a c e ty lc h o lin e  in  th e  m ediation 
of  nerve impulses a t  mammalian neuromuscular ju n c tio n s  . Again, 
d e sp ite  much sp e c u la tio n , we have as y e t no d e ta ile d  o v e ra ll  exp lanan tion  
supported  by adequate d a ta  o f th e  mechanism o f th ese  a ilm en ts
/u .
3 ) .  P h o to se n s itiz a tio n .
The basic  mechanisms by which drug-induced p h o to se n s itiv ity  
re ac tio n s  a re  m ediated are  o u tlin ed  in  scheme 4 . P h o to se n s itiz a tio n  
may take  th e  form o f an exaggerated sunburn (p h o to to x ic ity )  o r may 
involve a delayed h y p e rse n s it iv ity  re a c tio n  (p h o to a lle rg y ). The form er 
process undoubtably takes p lace  w ith  phenoth iazine and th e  l a t e r  
mechanism probably p lay s  a p a r t  in  the o v e ra ll  p ic tu re .
( i ) . P h o to to x ic ity .
The o ra l in g e s tio n  o f phenoth iazine o r  th io n o l and subsequent 
i r r a d ia t io n  o f exposed sk in  has been shown to  give r i s e  to  a  hyperaemic 
response and o th e rs  have n o ticed  a  re a c tio n  resem bling exaggerated 
sunburn a f t e r  o ra l in g e s tio n  o f  r e la t iv e ly  h igh  doses o f pheno th iazine . 
One in te r e s t in g  re p o r t  s ta te s  th a t  the exposure to  in f r a - re d  ra d ia tio n  
o f h o rses , dogs and mice p rev io u sly  tre a te d  w ith  phenoth iazine re s u l te d  
in  rap id  desquamation and the f a l l in g  out o f  h a i r  over th e  whole body 
su rfa ce . Severe sk in  pigm entation was a lso  seen in  dogs. Such e f fe c ts  
were no t produced by i r r a d ia t io n  in  th e  absence o f in g ested  
phenoth iazine
These re a c tio n s  to  system ic ad m in is tra tio n  would seem to  be 
pho to tox ic  in  n a tu re  and a re  probably tra c e a b le  to  a  p h o to se n s itiz a tio n  
p roduct o r  products produced e i th e r  d i r e c t ly  o r in d ir e c t ly  by th e  
p resence o f the  phenothiazone /  leucophenothiazone o r  th io n o l /  leu co - 
th io n o l redox systems p re se n t in  th e  t is s u e s  r e s u l t in g  from th e  o x id a tio n  
o f  absorbed phenoth iazine W hilst th e  i n i t i a l  s te p  o f a l l
p h o to se n s it iv ity  re a c tio n s  must be th e  ab so rp tio n  o f l i g h t  by th e  
chem ical o r  i t s  m e tab o lites , th e  p re c ise  mechanisms o f p h o to se n s it iv ity  
a re , f o r  the most p a r t ,  unknown ^77, 278^
One re a c tio n  th a t  has been adequate ly  in v e s tig a te d  fo r  th e  






















which occurs in  young c a t t l e  dosed w ith  phenoth iazine and subsequently  
exposed to  s u n lig h t.  The in je c t io n  o f phenothiazone, leucophenothiazone 
su lp h a te , th io n o l o r  phenoth iazine sulphoxide in to  th e  a n te r io r  chamber 
o f  th e  c a l f  eye followed by a  d e lib e ra te  exposure to  b r ig h t s u n lig h t 
f o r  90 minutes re su lte d  in  th e  development o f an in te n se  k e r a t i t i s  some 
20 hours l a t e r .  The in je c t io n  o f o th e r agen ts whose p h o to se n s itiz in g  
a c t iv i t y  i s  w ell e s ta b lish e d  (haem atoporphyrin, p h y llo e ry th r in , hypercin, 
ro se  bengal) a lso  produced in te n se  k e r a t i t i s  under th ese  con d itio n s  
whereas co n tro l in je c tio n s  o f  s a lin e  d id  n o t.
P ost mortem in v e s tig a tio n s  o f o th e r  ca lves dosed w ith  phenoth iazine
showed th a t  the only d e r iv a tiv e  p re se n t in  the la c r im a l f lu id  and
aqueous humour o f th e  eye was th e  su lphox ide; no sulphoxide being
d e tec ted  in  the  analogous p a r ts  o f  sheep who a re  no t normally su sc e p tib le
to  th i s  a ilm en t except when given massive doses. The e f fe c tiv e
wavelength o f  l i g h t  which produced th i s  co n d itio n  la y  between 320 and
360 nm which corresponds to  an ab so rp tio n  maximum in  th e  sulphoxide
spectrum, phenoth iazine, phenothiazone and th io n o l ly in g  o u ts id e  th is
range (see Table 1 and 12) in  a d d itio n , a  sheep dosed w ith
122th e  sulphoxide was shown to  subsequently  develop k e r a t i t i s  . I t  was 
concluded th a t  th i s  p a r t ic u la r  a ilm ent was a  p h o to se n s itiz a tio n  
phenomenon and th a t  the photodynamic substance was phenoth iazine 
su lphox ide.
The to p ic a l  a p p lic a tio n  o f phenoth iazine  mixed w ith  a lco h o l o r  
wool f a t  ( la n o lin )  to  the forearm o f v o lu n teers  was shown to  produce 
no i r r i t a t i o n  even when exposed to  i r r a d ia t io n  and th ese  in v e s tig a to rs  
concluded th a t  the u n d esirab le  e f fe c ts  rep o rted  in  o th e r  workers were 
n o t due to  a  lo c a l  mechanism but sy s tem ica lly  m ediated However, a
case has been c i te d  where an in d iv id u a l su ffe red  p h o to se n s itiz a tio n  and 
su n b u m -lik e  i r r i t a t i o n  o f th e  sk in  on p a r ts  o f  th e  body contam inated 
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e x p o se d , b u t uncon tam in ated  p a r ts  o f  th e  body . I t  has b een  s t a t e d  
t h a t  s k in  c o n t a c t  w ith  f r e s h l y  made p h e n o th ia z in e  w i l l  n o t  in d u ce  a  
d e r m a t it ic  r e a c t io n  b u t once i t  has b een  a llo w e d  t o  o x id is e  th e n  such
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a d v e r se  r e a c t io n s  a re  a lm o st  c e r t a in  , The u se  o f  a  s o lv e n t  may 
enhance th e  e n t iy  o f  th e  compound in t o  th e  l i p i d  b a r r ie r  o f  th e  s k in .
I t  i s  n o t y e t  c l e a r  w hich  d e r iv a t iv e  o f  p h e n o th ia z in e  o r  w h eth er  o r  
n o t a l l  o f  th e  d e r iv a t iv e s  a r e  th e  d e r m a t it ic  a g e n t s  a lth o u g h  i t  i s  
now f a i r l y  c e r t a in  th a t  t o p ic a l  a p p l ic a t io n  a lo n e  may in d u ce  a  
l o c a l i s e d  r e a c t io n  in  c e r t a in  in d iv id u a ls .  The a d d i t io n a l  c o m p lic a t io n  
t h a t  f in e  p a r t ic u la t e  p h e n o th ia z in e  may e n te r  th e  body by in h a la t io n  
w h i l s t  sp r a y in g  must a l s o  be borne in  mind.
( i i ) .  P h o to a l le r g y .
A cute d e r m a t it is  w ith  e x f o l i a t i o n  on th e  ex p o sed  a r e a s  o f  th e
th e  body has b een  d e s c r ib e d  i n  p a t ie n t s  who had worked on t h e  t a b le t in g
o f  p h e n o th ia z in e , u n d ou b tab ly  under c o n s ta n t  e x p o su r e , and i t  may be
s i g n i f i c a n t  t h a t  v i r t u a l l y  a l l  o f  t h e  c a s e s  w here s im i la r  t o x i c
r e a c t io n s  have o ccu rred  in  man th e r e  h as been  r e p e a te d  a d m in is tr a t io n
211
o r  c o n ta c t  w ith  p h e n o th ia z in e  . T h is p h o to c o n ta c t  d e r m a t i t i s  p rob ab ly  
has an im m u n olog ica l b a s i s ,  s im i la r  to  th a t  due to  ch lo rp ro m a z in e , and 
c o u ld  b e  c l a s s i f i e d  a s  p h o t o a l le r g ic  i n  n a tu r e .
The f i r s t  s ta g e  i n  t h i s  p ro ced u re  i s  th e  in t e r a c t io n  o f  th e  drug  
w ith  l i g h t  to  form  a  p h o to a c t iv a te d  compound; a  h ap ten  w hich  can  th en  
com bine w ith  a  p r o t e in  o r  o th e r  m acrom olecu le ( c a r r i e r )  to  form  th e  
a l le r g e n  p o s s e s s in g  im m u n olog ica l p r o p e r t ie s  (Schem e 4 ) . The mechanism  
o f  th e  su b seq u en t im m u n olog ica l r e sp o n se  i s ,  presu m ab ly , s im i la r  to  
o th e r  ty p e s  o f  d e la y ed  h y p e r s e n s i t iv i t y  m ed iated  through  im m u n o lo g ic a lly
280com p etent c e l l s ,  p r in c ip a l ly  lym p h ocy tes
The i d e n t i t y  o f  th e  r e a c t iv e  s p e c ie s  in  m ost in s t a n c e s  i s  n o t  
known to  any d egree  o f  c e r t a in t y  a lth o u g h  thezre i s  much s p e c u la t io n .
(  V
For chlorprom azine and o th e r  2-ch lo ropheno th iaz ines (eg. perphenazine, 
p ro ch lo rp eraz in e) the p h o to e x c ita h il i ty  o f  the ch lo rin e  moiety has 
been im p lica ted  in  which the  a c tiv a te d  molecule re a c ts  w ith  a  f re e  
amino group on the c a r r i e r  p ro te in  to  form th e  an tig en  (Bq. 6 ) .
278W ithout th e  ch lo rin e  moiety th i s  p a r t ic u la r  re a c tio n  cannot occur * 
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PZ -  d  > PZ -  Cl H2N -(P ro te in ) ------^  PZ-W H -(Protein)
an tig en
(% . 6 )(PZ—Cl = ground .s ta te ;  PZ —Cl = e x c ite d  s ta te )
However, i t  i s  p o ss ib le  th a t  th e  p aren t m olecule i t s e l f  i s  
capable o f  a  p h o to se n s itiz in g  e f f e c t .  O ther compounds possessing  
u n sa tu ra ted  t r i c y c l i c  arom atic s tr u c tu r e s ,  u su a lly  co n ta in in g  n itro g en  
o r oxygen atoms which have lone p a ir s  o f  e le c tro n s  which a re  no t 
involved in  a c tu a l  bonding (e^ . methylene b lu e , ^ )  have been shown to  
re q u ire  only a  sm all amount o f  p h o tic  energy to  a c t iv a te  them. I t  has 
been suggested th a t  pheno th iaz ines, ap p aren tly  through dimer p roducts 
p o ss ib ly  a c tin g  as f re e  r a d ic a ls ,  produce th e  a l le rg y  and i t  has been 
shown th a t  phenoth iazine i t s e l f  i s  capable o f forming such dim eric and 
polym eric products (Scheme 5) ^^^282,283^
I f  th i s  i s  t r u ly  the  mechanism then  a  c r o s s - s e n s i t iv i ty  should  
be p re se n t w ith in  a s e n s it iz e d  in d iv id u a l to  s t r u c tu r a l ly  s im ila r  
m olecules. This has been shown to  be th e  case fo r  promazine and 
chlorprom azine bu t such s tu d ie s  have no t included  th e  p a ren t compound 
i t s e l f .
e S h  e
p h e n a z o t h i o n i u m  








( g r e e n  o x i d a t i o n  p ro d u c t )
t r im e r
t e t r a m e r
polymers
Scheme 5* Polym erization  o f p h en o th iaz ine . (fîefs 1 ^ ,1 5 ).
5. CONCLUDING REMARKS
For a compound th a t  has enjoyed ex tensive  and widespread 
use f o r  more than two decades s u p ris in g ly  l i t t l e  i s  known w ith  any 
c e r ta in ty  about i t s  mode o f a c tio n . I t s  d ec lin e  from p o p u la r ity  in  
the  mid IçôO 's meant th a t  many o f th e  modern in v e s tig a tiv e  techniques 
now re a d ily  a c c e ss ib le  could no t be a p p lied  to  th e  study o f th is  drug 
and the  in form ation  th a t  i s  a v a ila b le  in  th e  l i t e r a t u r e  i s  u su a lly  
incom plete o r inconclusive  when viewed under the  l i g h t  o f  modem 
s c ie n t i f i c  assessm ent.
What i s  apparen t i s  th a t  to  be e f fe c t iv e  th e  compound i s  u su a lly  
given in  la rg e  doses and because o f  i t s  high l i p i d  s o lu b i l i ty  becomes 
w idely d is t r ib u te d  around th e  body. Here i t  undegoes enzym atically  
ca ta ly sed  chemical a l t e r a t io n s ,  mainly ox id a tio n s  o f th e  carbon and 
su lphur atoms and con jugation  (condensation) re a c tio n s  w ith  g lucuron ic 
and su lp h u ric  a c id s .
The in s e c t ic id a l ,  a n t ib a c te r ia l  and an th e lm in tic  a c tio n s  o f 
phenoth iazine and th e  p roduction  o f the  unwanted to x ic  e f fe c ts  presumably 
a r i s e  from common underly ing  mechanisms ; the  l a t t e r  perhaps m an ifest 
them selves in  anim als which may have an environm ental o r  g en e tic  
p re d isp o s itio n  to  such re a c t io n s .  Three b a s ic  ways in  which the  
phenoth iazine molecule in te r a c ts  w ith  th e  c e l lu la r  components o f  l iv in g  
t i s s u e  to produce th ese  observed e f fe c ts  have become apparen t from 
ev a lu a tin g  the  a v a ila b le  l i t e r a t u r e .
l ) . N on-specific macromolecular d is ru p tio n
-  high l i p i d  s o lu b i l i ty  perm its d is ru p tio n  o f th e  l i p i d  phase 
o f membranes.
-  van der Waals in te ra c tio n s  allow n o n -sp ec ific  b ind ing  to  th e  
p ro te in  phase o f membranes and to  p ro te in s  in c lu d in g  enzymes.
2 ). Redox systems
-  perm its energy t r a n s f e r ;  d is ru p ts  c e l lu la r  components, in h ib i t s  
enzyme system s, p h o to se n s itiz a tio n  (p h o to to x ic ).
3 ) .  A llergen form ation
-  p h o to ac tiv a tio n ; p h o to se n s itiz a tio n  (p h o to a lle rg y ) , anaphy lax is.
I t  i s  probable th a t  th ese  th re e  b a s ic  mechanisms ex p la in  most, i f  
no t a l l ,  o f the  a c tio n s  o f pheno th iazine . However, much work s t i l l  
remains to  be undertaken to  uncover th e  e lu s iv e  d e ta i l s  and w ith  
phenoth iazine now being th e  p a re n t compound o f a  m u ltitu d e  o f ex ten s iv e ly  
used th e ra p e u tic  agen ts perhaps the  tim e i s  r ip e  fo r  th e  compound to  be 
re in v e s tig a te d  using  modem s c ie n t i f i c  techn iques.
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